Maurizio Fava - Publications

Affiliations: 
MGH Depression Clinical and Research Program 
Area:
Psychiatry

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Lee MK, Hong JP, Fava M, Mischoulon D, Kim H, Park MJ, Kim EJ, Jeon HJ. Obsessive Thought, Compulsive Behavior, and Their Associations With Suicide Ideation and Attempts and Major Depressive Disorder: A Nationwide Community Sample of Korean Adults. The Journal of Nervous and Mental Disease. PMID 34238894 DOI: 10.1097/NMD.0000000000001382  0.68
2021 Iovieno N, Papakostas GI, Feeney A, Fava M, Mathew SJ, Iosifescu DI, Murrough JW, Macaluso M, Hock RS, Jha MK. Vortioxetine Versus Placebo for Major Depressive Disorder: A Comprehensive Analysis of the Clinical Trial Dataset. The Journal of Clinical Psychiatry. 82. PMID 34133089 DOI: 10.4088/JCP.20r13682  0.64
2021 Feeney A, Hock RS, Freeman MP, Flynn M, Hoeppner B, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, Debattista C, Ionescu DF, Fava M, Papakostas GI. The effect of single administration of intravenous ketamine augmentation on suicidal ideation in treatment-resistant unipolar depression: Results from a randomized double-blind study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 49: 122-132. PMID 34090255 DOI: 10.1016/j.euroneuro.2021.04.024  0.64
2021 Wright AC, Cather C, Farabaugh A, Terechina O, Pedrelli P, Nyer M, Fava M, Holt DJ. Relationship between cannabis use and psychotic experiences in college students. Schizophrenia Research. 231: 198-204. PMID 33887647 DOI: 10.1016/j.schres.2021.04.004  0.32
2021 Nasiriavanaki Z, Barbour T, Farabaugh AH, Fava M, Holmes AJ, Tootell RBH, Holt DJ. Anxious attachment is associated with heightened responsivity of a parietofrontal cortical network that monitors peri-personal space. Neuroimage. Clinical. 30: 102585. PMID 33773165 DOI: 10.1016/j.nicl.2021.102585  0.6
2021 Kim H, Kim Y, Fava M, Mischoulon D, Shin MH, Lee DY, Jeon HJ. Increased risk of depression before and after unilateral or bilateral oophorectomy: A self-controlled case series study using a nationwide cohort in South Korea. Journal of Affective Disorders. 285: 47-54. PMID 33631480 DOI: 10.1016/j.jad.2021.02.003  0.68
2021 Wang D, Peng X, Pelletier-Baldelli A, Orlov N, Farabaugh A, Nasr S, Eryilmaz H, Fava M, Holmes AJ, Roffman JL, Liu H, Holt DJ. Altered temporal, but intact spatial, features of transient network dynamics in psychosis. Molecular Psychiatry. PMID 33462330 DOI: 10.1038/s41380-020-00983-1  0.32
2020 Lamon-Fava S, So J, Mischoulon D, Ziegler TR, Dunlop BW, Kinkead B, Schettler PJ, Nierenberg AA, Felger JC, Maddipati KR, Fava M, Rapaport MH. Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 164: 102219. PMID 33316626 DOI: 10.1016/j.plefa.2020.102219  0.68
2020 Choi KW, Jang EH, Kim AY, Kim H, Park MJ, Byun S, Fava M, Mischoulon D, Papakostas GI, Yu HY, Jeon HJ. Predictive inflammatory biomarkers for change in suicidal ideation in major depressive disorder and panic disorder: A 12-week follow-up study. Journal of Psychiatric Research. 133: 73-81. PMID 33310645 DOI: 10.1016/j.jpsychires.2020.12.011  0.68
2020 Park ER, Sylvia LG, Streck JM, Luberto CM, Stanton AM, Perez GK, Baim M, Bliss CC, Convery MS, Crute S, Denninger JW, Donelan K, Dossett ML, Fava M, Fredriksson S, et al. Launching a resiliency group program to assist frontline clinicians in meeting the challenges of the COVID-19 pandemic: Results of a hospital-based systems trial. General Hospital Psychiatry. PMID 33229013 DOI: 10.1016/j.genhosppsych.2020.10.005  0.56
2020 Fava M, Mazzone E, Freeman M, Flynn M, Judge H, Hoeppner B, Hock RS, Shui A, Macaluso M, Morrison MF, Carpenter LL, Shelton R, Zajecka J, Papakostas GI. Double-blind, placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depression. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 32: e16-e24. PMID 33125454 DOI: 10.12788/acp.0003  0.64
2020 Jha MK, Fava M, Minhajuddin A, Chin Fatt C, Mischoulon D, Cusin C, Trivedi MH. Association of anger attacks with suicidal ideation in adults with major depressive disorder: Findings from the EMBARC study. Depression and Anxiety. PMID 33038902 DOI: 10.1002/da.23095  0.68
2020 Sakurai H, Jain F, Foster S, Pedrelli P, Mischoulon D, Fava M, Cusin C. Long-term outcome in outpatients with depression treated with acute and maintenance intravenous ketamine: A retrospective chart review. Journal of Affective Disorders. 276: 660-666. PMID 32871698 DOI: 10.1016/J.Jad.2020.07.089  0.68
2020 Shelton RC, Fava M, Freeman MP, Thase ME, Papakostas GI, Jha MK, Trivedi MH, Dirks B, Liu K, Stankovic S. Effect of adjunctive pimavanserin on suicidal ideation in patients with major depression: Analysis of the CLARITY study. Journal of Affective Disorders. 277: 478-485. PMID 32871535 DOI: 10.1016/j.jad.2020.08.051  0.64
2020 Papakostas GI, Fava M, Freeman MP, Shelton RC, Thase ME, Jha MK, Trivedi MH, Dirks B, Liu K, Stankovic S. Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity study. International Clinical Psychopharmacology. PMID 32804742 DOI: 10.1097/YIC.0000000000000328  0.64
2020 Johe KK, Kay G, Kumar S, Burdick KE, McIntyre RS, Papakostas GI, Fava M. NSI-189 phosphate, a novel neurogenic compound, selectively benefits moderately depressed patients: A post-hoc analysis of a phase 2 study of major depressive disorder. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 32: 182-196. PMID 32722729  0.64
2020 Dichtel LE, Carpenter LL, Nyer M, Mischoulon D, Kimball A, Deckersbach T, Dougherty DD, Schoenfeld DA, Fisher L, Cusin C, Dording C, Trinh NH, Pedrelli P, Yeung A, Farabaugh A, ... ... Fava M, et al. Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study. The American Journal of Psychiatry. appiajp202019080844. PMID 32660299 DOI: 10.1176/Appi.Ajp.2020.19080844  0.68
2020 Dichtel LE, Nyer M, Dording C, Fisher LB, Cusin C, Shapero BG, Pedrelli P, Kimball AS, Rao EM, Mischoulon D, Fava M, Miller KK. Effects of Open-Label, Adjunctive Ganaxolone on Persistent Depression Despite Adequate Antidepressant Treatment in Postmenopausal Women: A Pilot Study. The Journal of Clinical Psychiatry. 81. PMID 32558402 DOI: 10.4088/Jcp.19M12887  0.68
2020 An JH, Park MJ, Fava M, Mischoulon D, Kim H, Jang J, Hong JP, Park JS, Jeon HJ. Comparisons Between Successful Versus Unsuccessful Switches From Benzodiazepines or Zolpidem (Z-Drug) to Controlled-Release Melatonin in Patients With Major Depressive Disorder and Insomnia. Frontiers in Psychiatry. 11: 444. PMID 32508689 DOI: 10.3389/fpsyt.2020.00444  0.68
2020 Papakostas GI, Salloum NC, Hock RS, Jha MK, Murrough JW, Mathew SJ, Iosifescu DV, Fava M. Efficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-Analysis. The Journal of Clinical Psychiatry. 81. PMID 32459407 DOI: 10.4088/Jcp.19R12889  0.64
2020 Perlis RH, Dowd D, Fava M, Lencz T, Krause DS. Randomized, controlled, participant- and rater-blind trial of pharmacogenomic test-guided treatment versus treatment as usual for major depressive disorder. Depression and Anxiety. PMID 32383277 DOI: 10.1002/da.23029  0.44
2020 Freeman MP, Hock RS, Papakostas GI, Judge H, Cusin C, Mathew SJ, Sanacora G, Iosifescu DV, DeBattista C, Trivedi MH, Fava M. Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder. Journal of Clinical Psychopharmacology. 40: 287-292. PMID 32332464 DOI: 10.1097/Jcp.0000000000001209  0.64
2020 Fava M, Dirks B, Freeman MP, Shelton RC, Thase ME, Trivedi MH, Papakostas GI, Liu K, Whitworth T, Stankovic S. 181 A Phase-2 Sequential Parallel Comparison Design Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder. Cns Spectrums. 25: 314-315. PMID 32331041 DOI: 10.1017/S1092852920000966  0.64
2020 Freeman MP, Fava M, Dirks B, Jha MK, Shelton RC, Thase ME, Trivedi MH, Papakostas GI, Liu K, Whitworth T, Stankovic S. 180 Improvement of Sexual Function Observed During Treatment of Major Depressive Disorder with Adjunctive Pimavanserin. Cns Spectrums. 25: 313-314. PMID 32331034 DOI: 10.1017/S1092852920000954  0.64
2020 Freeman MP, Fava M, Dirks B, Jha MK, Papakostas GI, Shelton RC, Thase ME, Trivedi MH, Liu K, Stankovic S. Improvement of sexual functioning during treatment of MDD with adjunctive pimavanserin: A secondary analysis. Depression and Anxiety. PMID 32301591 DOI: 10.1002/da.23017  0.64
2020 Jha MK, Fava M, Minhajuddin A, Chin Fatt C, Mischoulon D, Wakhlu N, Trombello JM, Cusin C, Trivedi MH. Anger attacks are associated with persistently elevated irritability in MDD: findings from the EMBARC study. Psychological Medicine. 1-9. PMID 32138798 DOI: 10.1017/S0033291720000112  0.68
2020 Cusin C, Sakurai H, Bentley K, Pedrelli P, Foster S, Fava M, Mischoulon D. All Suicidal Ideation Is Not Created Equal: Two Cases of Suicide Attempts During Maintenance Ketamine Treatment. The American Journal of Psychiatry. 177: 173-174. PMID 32008389 DOI: 10.1176/Appi.Ajp.2019.19050508  0.68
2020 Salloum NC, Fava M, Ball S, Papakostas GI. Success and efficiency of phase 2/3 adjunctive trials for MDD funded by industry: a systematic review. Molecular Psychiatry. PMID 31988433 DOI: 10.1038/s41380-020-0646-3  0.64
2020 Kim H, Kim Y, Baek JH, Fava M, Mischoulon D, Nierenberg AA, Choi KW, Na EJ, Shin MH, Jeon HJ. Predictive factors of diagnostic conversion from major depressive disorder to bipolar disorder in young adults ages 19-34: A nationwide population study in South Korea. Journal of Affective Disorders. 265: 52-58. PMID 31957692 DOI: 10.1016/j.jad.2020.01.009  0.68
2020 Jha M, Fava M, Minhajuddin A, Fatt CC, Mischoulon D, Cusin C, Trivedi M. Association of Anger Attacks With Persistently Elevated Suicidality in Depressed Patients: Do Early Improvements in Irritability Reduce the Risk? Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.298  0.68
2020 Jha M, Fava M, Minhajuddin A, Fatt CC, Mischoulon D, Wakhlu N, Trombello J, Cusin C, Trivedi M. Neural Circuits Linking Irritability and Anger Attacks in Major Depressive Disorder: Findings From EMBARC Study Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.208  0.68
2019 Barbour T, Holmes AJ, Farabaugh AH, DeCross SN, Coombs G, Boeke EA, Wolthusen RPF, Nyer M, Pedrelli P, Fava M, Holt DJ. Elevated Amygdala Activity in Young Adults With Familial Risk for Depression: A Potential Marker of Low Resilience. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 31948836 DOI: 10.1016/J.Bpsc.2019.10.010  0.6
2019 Baker A, Simon N, Keshaviah A, Farabaugh A, Deckersbach T, Worthington JJ, Hoge E, Fava M, Pollack MP. Anxiety Symptoms Questionnaire (ASQ): development and validation. General Psychiatry. 32: e100144. PMID 31922090 DOI: 10.1136/gpsych-2019-100144  0.68
2019 Pedrelli P, Fisher LB, Nyer M, Shapero BG, Farabaugh A, Hayden ER, Levine MT, Fava M, Weiss RD, Borsari B, Merrill JE. Evaluating the combination of a Brief Motivational Intervention plus Cognitive Behavioral Therapy for Depression and heavy episodic drinking in college students. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. PMID 31855009 DOI: 10.1037/Adb0000538  0.32
2019 Kimball A, Dichtel LE, Nyer MB, Mischoulon D, Fisher LB, Cusin C, Dording CM, Trinh NH, Yeung A, Haines MS, Sung JC, Pinna G, Rasmusson AM, Carpenter LL, Fava M, et al. The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause. Psychoneuroendocrinology. 104512. PMID 31780185 DOI: 10.1016/J.Psyneuen.2019.104512  0.68
2019 Sakurai H, L Carpenter L, R Tyrka A, Price LH, I Papakostas G, Dording CM, Yeung AS, Cusin C, Ludington E, Bernard-Negron R, Fava M, Mischoulon D. Dose increase of S-Adenosyl-Methionine and escitalopram in a randomized clinical trial for major depressive disorder. Journal of Affective Disorders. 262: 118-125. PMID 31733455 DOI: 10.1016/J.Jad.2019.10.040  0.68
2019 Dotson S, Mischoulon D, Lee H, Fava M. Rising placebo response rates threaten the validity of antipsychotic meta-analyses. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 31: 249-259. PMID 31675386  0.68
2019 Kim K, Jang EH, Kim AY, Fava M, Mischoulon D, Papakostas GI, Kim H, Na EJ, Yu HY, Jeon HJ. Pre-treatment peripheral biomarkers associated with treatment response in panic symptoms in patients with major depressive disorder and panic disorder: A 12-week follow-up study. Comprehensive Psychiatry. 95: 152140. PMID 31669792 DOI: 10.1016/j.comppsych.2019.152140  0.68
2019 Kim H, Kim Y, Myung W, Fava M, Mischoulon D, Lee U, Lee H, Jin Na E, Woo Choi K, Shin MH, Jin Jeon H. Risks of suicide attempts after prescription of zolpidem in people with depression: A nationwide population study in South Korea. Sleep. PMID 31586200 DOI: 10.1093/sleep/zsz235  0.68
2019 Fava M, Dirks B, Freeman MP, Papakostas GI, Shelton RC, Thase ME, Trivedi MH, Liu K, Stankovic S. A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin in Patients With Major Depressive Disorder and an Inadequate Response to Therapy (CLARITY). The Journal of Clinical Psychiatry. 80. PMID 31556975 DOI: 10.4088/JCP.19m12928  0.64
2019 Na EJ, Choi KW, Hong JP, Cho MJ, Fava M, Mischoulon D, Jeon HJ. Paranoid Ideation Without Psychosis Is Associated With Depression, Anxiety, and Suicide Attempts in General Population. The Journal of Nervous and Mental Disease. PMID 31503180 DOI: 10.1097/NMD.0000000000001050  0.68
2019 Salloum NC, Fava M, Hock RS, Freeman MP, Flynn M, Hoeppner B, Cusin C, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, Debattista C, Ionescu DF, Papakostas GI. Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression. Journal of Affective Disorders. 260: 131-139. PMID 31494365 DOI: 10.1016/J.Jad.2019.09.017  0.64
2019 An JH, Jang EH, Kim AY, Fava M, Mischoulon D, Papakostas GI, Na EJ, Jang J, Yu HY, Hong JP, Jeon HJ. Ratio of plasma BDNF to leptin levels are associated with treatment response in major depressive disorder but not in panic disorder: A 12-week follow-up study. Journal of Affective Disorders. 259: 349-354. PMID 31465895 DOI: 10.1016/j.jad.2019.08.021  0.68
2019 Na EJ, Choi J, Kim D, Kwon H, Lee Y, Lee G, Fava M, Mischoulon D, Jang J, Jeon HJ. Design and Methods of the Korean National Investigations of 70,000 Suicide Victims Through Police Records (The KNIGHTS Study). Psychiatry Investigation. PMID 31455061 DOI: 10.30773/pi.2019.07.14  0.68
2019 Choi KW, Kim Y, Fava M, Mischoulon D, Na EJ, Kim SW, Shin MH, Chung MK, Jeon HJ. Increased morbidity of major depressive disorder after thyroidectomy: a nationwide population-based study in South Korea. Thyroid : Official Journal of the American Thyroid Association. PMID 31422760 DOI: 10.1089/thy.2019.0091  0.68
2019 Sakurai H, Dording C, Yeung A, Foster S, Jain F, Chang T, Trinh NH, Bernard R, Boyden S, Iqbal SZ, Wilkinson ST, Mathew SJ, Mischoulon D, Fava M, Cusin C. Longer-term open-label study of adjunctive riluzole in treatment-resistant depression. Journal of Affective Disorders. 258: 102-108. PMID 31400624 DOI: 10.1016/j.jad.2019.06.065  0.68
2019 Baek JH, Heo JY, Fava M, Mischoulon D, Choi KW, Na EJ, Cho H, Jeon HJ. Effect of Korean Red Ginseng in individuals exposed to high stress levels: a 6-week, double-blind, randomized, placebo-controlled trial. Journal of Ginseng Research. 43: 402-407. PMID 31308812 DOI: 10.1016/j.jgr.2018.03.001  0.68
2019 Nyer M, Hopkins LB, Farabaugh A, Nauphal M, Parkin S, McKee MM, Miller KK, Streeter C, Uebelacker LA, Fava M, Alpert JE, Pedrelli P, Mischoulon D. Community-Delivered Heated Hatha Yoga as a Treatment for Depressive Symptoms: An Uncontrolled Pilot Study. Journal of Alternative and Complementary Medicine (New York, N.Y.). PMID 31290694 DOI: 10.1089/Acm.2018.0365  0.88
2019 Kim K, Shin JH, Myung W, Fava M, Mischoulon D, Papakostas GI, Choi KW, Na EJ, Seo SW, Seong JK, Jeon HJ. Deformities of the Globus Pallidus are Associated with Severity of Suicidal Ideation and Impulsivity in Patients with Major Depressive Disorder. Scientific Reports. 9: 7462. PMID 31097766 DOI: 10.1038/s41598-019-43882-4  0.68
2019 Na EJ, Lee H, Myung W, Fava M, Mischoulon D, Paik JW, Hong JP, Choi KW, Kim H, Jeon HJ. Risks of Completed Suicide of Community Individuals with ICD-10 Disorders Across Age Groups: A Nationwide Population-Based Nested Case-Control Study in South Korea. Psychiatry Investigation. 16: 314-324. PMID 31042694 DOI: 10.30773/pi.2019.02.19  0.68
2019 Brown HE, Freudenreich O, Fan X, Heard SO, Goff D, Petrides G, Harrington AL, Kane JM, Judge H, Hoeppner B, Fava M, Perlis RH. Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia: A Randomized Clinical Trial. Jama Psychiatry. PMID 30916714 DOI: 10.1001/Jamapsychiatry.2019.0151  0.44
2019 DeCross SN, Farabaugh AH, Holmes AJ, Ward M, Boeke EA, Wolthusen RPF, Coombs G, Nyer M, Fava M, Buckner RL, Holt DJ. Increased amygdala-visual cortex connectivity in youth with persecutory ideation. Psychological Medicine. 1-11. PMID 30744715 DOI: 10.1017/S0033291718004221  0.6
2019 Choi KW, Na EJ, Hong JP, Cho MJ, Fava M, Mischoulon D, Jeon HJ. Comparison of suicide attempts in individuals with major depressive disorder with and without history of subthreshold hypomania: A nationwide community sample of Korean adults. Journal of Affective Disorders. 248: 18-25. PMID 30710859 DOI: 10.1016/j.jad.2019.01.022  0.68
2019 Freeman MP, Papakostas GI, Hoeppner B, Mazzone E, Judge H, Cusin C, Mathew S, Sanacora G, Iosifescu D, DeBattista C, Trivedi MH, Fava M. Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression. Journal of Psychiatric Research. 110: 166-171. PMID 30641350 DOI: 10.1016/J.Jpsychires.2019.01.010  0.64
2019 Papakostas GI, Johe K, Hand H, Drouillard A, Russo P, Kay G, Kashambwa R, Hoeppner B, Flynn M, Yeung A, Martinson MA, Fava M. A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder. Molecular Psychiatry. PMID 30626911 DOI: 10.1038/S41380-018-0334-8  0.64
2019 Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, et al. Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Molecular Psychiatry. PMID 30617276 DOI: 10.1038/S41380-018-0311-2  0.64
2019 Thomas G, Dording C, Foster S, Yeung A, Uchida M, Hamblin MR, Bui E, Fava M, Mischoulon D, Iosifescu DV, Cassano P. S198. Effects of Transcranial Photobiomodulation With Near-Infrared Light on Sexual Dysfunction Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.949  0.68
2018 Sarris J, Murphy J, Mischoulon D, Papakostas GI, Fava M, Berk M, Ng CH. Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses. Focus (American Psychiatric Publishing). 16: 328-340. PMID 32015713 DOI: 10.1176/appi.focus.16304  0.68
2018 Park MJ, Choi KW, Na EJ, Hong JP, Cho MJ, Fava M, Mischoulon D, Jeon HJ. Multiple types of somatic pain increase suicide attempts and depression: A nationwide community sample of Korean adults. Comprehensive Psychiatry. 90: 43-48. PMID 30684832 DOI: 10.1016/j.comppsych.2018.12.006  0.68
2018 Salloum NC, Fava M, Freeman MP, Flynn M, Hoeppner B, Hock RS, Cusin C, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, Debattista C, Ionescu DF, Papakostas GI. Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression. Depression and Anxiety. PMID 30597688 DOI: 10.1002/Da.22875  0.64
2018 Choi KW, Jang EH, Kim AY, Fava M, Mischoulon D, Papakostas GI, Kim DJ, Kim K, Yu HY, Jeon HJ. Heart rate variability for treatment response between patients with major depressive disorder versus panic disorder: A 12-week follow-up study. Journal of Affective Disorders. 246: 157-165. PMID 30583140 DOI: 10.1016/j.jad.2018.12.048  0.68
2018 Kinrys G, Gold AK, Pisano VD, Freeman MP, Papakostas GI, Mischoulon D, Nierenberg AA, Fava M. Tachyphylaxis in major depressive disorder: A review of the current state of research. Journal of Affective Disorders. 245: 488-497. PMID 30439676 DOI: 10.1016/j.jad.2018.10.357  0.68
2018 Perlis RH, Fava M, McCoy TH. Can electronic health records revive central nervous system clinical trials? Molecular Psychiatry. PMID 30429581 DOI: 10.1038/s41380-018-0278-z  0.44
2018 Shapero BG, Farabaugh A, Terechina O, DeCross S, Cheung JC, Fava M, Holt DJ. Understanding the effects of emotional reactivity on depression and suicidal thoughts and behaviors: Moderating effects of childhood adversity and resilience. Journal of Affective Disorders. 245: 419-427. PMID 30423470 DOI: 10.1016/j.jad.2018.11.033  0.32
2018 Cassano P, Petrie SR, Mischoulon D, Cusin C, Katnani H, Yeung A, De Taboada L, Archibald A, Bui E, Baer L, Chang T, Chen J, Pedrelli P, Fisher L, Farabaugh A, ... ... Fava M, et al. Transcranial Photobiomodulation for the Treatment of Major Depressive Disorder. The ELATED-2 Pilot Trial. Photomedicine and Laser Surgery. PMID 30346890 DOI: 10.1089/Pho.2018.4490  0.88
2018 Ionescu DF, Bentley KH, Eikermann M, Taylor N, Johnson-Akeju O, Swee MB, Pavone KJ, Petrie SR, Dording C, Mischoulon D, Alpert JE, Brown EN, Baer L, Nock MK, Fava M, et al. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial. Journal of Affective Disorders. 243: 516-524. PMID 30286416 DOI: 10.1016/J.Jad.2018.09.037  0.88
2018 Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, et al. Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Molecular Psychiatry. PMID 30283029 DOI: 10.1038/S41380-018-0256-5  0.64
2018 Kim H, Choi KW, Na EJ, Hong JP, Fava M, Mischoulon D, Cho H, Jeon HJ. Anxiety attacks with or without life-threatening situations, major depressive disorder, and suicide attempt: a nationwide community sample of Korean adults. Psychiatry Research. 270: 257-263. PMID 30273856 DOI: 10.1016/j.psychres.2018.09.050  0.68
2018 Choi KW, Na EJ, Fava M, Mischoulon D, Cho H, Jeon HJ. Increased adrenocorticotropic hormone (ACTH) levels predict severity of depression after six months of follow-up in outpatients with major depressive disorder. Psychiatry Research. 270: 246-252. PMID 30269042 DOI: 10.1016/j.psychres.2018.09.047  0.68
2018 Laferton JAC, Vijapura S, Baer L, Clain AJ, Cooper A, Papakostas G, Price LH, Carpenter LL, Tyrka AR, Fava M, Mischoulon D. Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT of Major Depression. Frontiers in Psychiatry. 9: 424. PMID 30245644 DOI: 10.3389/Fpsyt.2018.00424  0.68
2018 Cassano P, Dording C, Thomas G, Foster S, Yeung A, Uchida M, Hamblin MR, Bui E, Fava M, Mischoulon D, Iosifescu DV. Effects of transcranial photobiomodulation with near-infrared light on sexual dysfunction. Lasers in Surgery and Medicine. PMID 30221776 DOI: 10.1002/Lsm.23011  0.68
2018 Pedrelli P, MacPherson L, Khan AJ, Shapero BG, Fisher LB, Nyer M, Cassano P, Parnarouskis L, Farabaugh A, Fava M, Silveri MM. Sex Differences in the Association between Heavy Drinking and Behavioral Distress Tolerance and Emotional Reactivity Among Non-Depressed College Students. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 29947730 DOI: 10.1093/Alcalc/Agy045  0.32
2018 Baek JH, Kim K, Hong JP, Cho MJ, Fava M, Mischoulon D, Chang SM, Kim JY, Cho H, Jeon HJ. Binge eating, trauma, and suicide attempt in community adults with major depressive disorder. Plos One. 13: e0198192. PMID 29927937 DOI: 10.1371/journal.pone.0198192  0.68
2018 Schuster RM, Pachas GN, Stoeckel L, Cather C, Nadal M, Mischoulon D, Schoenfeld DA, Zhang H, Ulysse C, Dodds EB, Sobolewski S, Hudziak V, Hanly A, Fava M, Evins AE. Phase IIb Trial of an α7 Nicotinic Receptor Partial Agonist With and Without Nicotine Patch for Withdrawal-Associated Cognitive Deficits and Tobacco Abstinence. Journal of Clinical Psychopharmacology. PMID 29912798 DOI: 10.1097/Jcp.0000000000000919  0.68
2018 Curren L, Huz I, McKee M, Traeger L, Bedoya CA, Chang TE, Cassano P, Fava M, Alpert J, Yeung A, Gilman SE, Trinh NH. Patient primary language in a culturally focused intervention for Latino Americans with depression. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 30: 84-90. PMID 29697708  0.56
2018 Nyer M, Gerbarg PL, Silveri MM, Johnston J, Scott TM, Nauphal M, Owen L, Nielsen GH, Mischoulon D, Brown RP, Fava M, Streeter CC. A randomized controlled dosing study of Iyengar yoga and coherent breathing for the treatment of major depressive disorder: Impact on suicidal ideation and safety findings. Complementary Therapies in Medicine. 37: 136-142. PMID 29609926 DOI: 10.1016/J.Ctim.2018.02.006  0.68
2018 Vance MC, Bui E, Hoeppner SS, Kovachy B, Prescott J, Mischoulon D, Walton ZE, Dong M, Nadal MF, Worthington JJ, Hoge EA, Cassano P, Orr EH, Fava M, de Vivo I, et al. Prospective association between major depressive disorder and leukocyte telomere length over two years. Psychoneuroendocrinology. 90: 157-164. PMID 29499556 DOI: 10.1016/J.Psyneuen.2018.02.015  0.68
2018 Gao J, Cahill CM, Huang X, Roffman JL, Lamon-Fava S, Fava M, Mischoulon D, Rogers JT. S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 29340929 DOI: 10.1007/S13311-017-0593-0  0.68
2017 Kim K, Kim SW, Myung W, Han CE, Fava M, Mischoulon D, Papakostas GI, Seo SW, Cho H, Seong JK, Jeon HJ. Reduced orbitofrontal-thalamic functional connectivity related to suicidal ideation in patients with major depressive disorder. Scientific Reports. 7: 15772. PMID 29150619 DOI: 10.1038/S41598-017-15926-0  0.68
2017 Yeung A, Wang F, Feng F, Zhang J, Cooper A, Hong L, Wang W, Griffiths K, Bennett K, Bennett A, Alpert J, Fava M. Outcomes of an online computerized cognitive behavioral treatment program for treating chinese patients with depression: A pilot study. Asian Journal of Psychiatry. PMID 29146042 DOI: 10.1016/J.Ajp.2017.11.007  0.56
2017 Choi KW, Na EJ, Hong JP, Cho MJ, Fava M, Mischoulon D, Cho H, Jeon HJ. Alcohol-induced disinhibition is associated with impulsivity, depression, and suicide attempt: A nationwide community sample of Korean adults. Journal of Affective Disorders. 227: 323-329. PMID 29132075 DOI: 10.1016/j.jad.2017.11.001  0.68
2017 Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Soskin DP, Fava M. Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]. Journal of Affective Disorders. 227: 198. PMID 29100152 DOI: 10.1016/J.Jad.2017.10.040  0.88
2017 Fava M, Freeman MP, Flynn M, Hoeppner BB, Shelton R, Iosifescu DV, Murrough JW, Mischoulon D, Cusin C, Rapaport M, Dunlop BW, Trivedi MH, Jha M, Sanacora G, Hermes G, et al. Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD). Brain Stimulation. PMID 29030111 DOI: 10.1016/J.Brs.2017.09.010  0.68
2017 Heo JY, Yi H, Fava M, Mischoulon D, Kim K, Yoon S, Jeon HJ, Lee JE. Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study. Psychiatry Investigation. 14: 491-498. PMID 28845177 DOI: 10.4306/pi.2017.14.4.491  0.68
2017 Lee HK, Kim JH, Fava M, Mischoulon D, Park JH, Shim EJ, Lee EH, Lee JH, Jeon HJ. Development and validation study of the Smartphone Overuse Screening Questionnaire. Psychiatry Research. 257: 352-357. PMID 28800515 DOI: 10.1016/j.psychres.2017.07.074  0.68
2017 Iovieno N, Shelton RC, Petrie SR, Cusin C, Fava M, Papakostas GI. Efficacy of Ziprasidone Augmentation of Escitalopram for Cognitive Symptoms of Major Depressive Disorder. The Journal of Clinical Psychiatry. PMID 28749091 DOI: 10.4088/JCP.16m10920  0.64
2017 Yuan H, Mischoulon D, Fava M, Otto MW. Circulating microRNAs as biomarkers for depression: Many candidates, few finalists. Journal of Affective Disorders. PMID 28673667 DOI: 10.1016/j.jad.2017.06.058  0.68
2017 Kim DJ, Kim K, Lee HW, Hong JP, Cho MJ, Fava M, Mischoulon D, Heo JY, Jeon HJ. Internet Game Addiction, Depression, and Escape From Negative Emotions in Adulthood: A Nationwide Community Sample of Korea. The Journal of Nervous and Mental Disease. PMID 28598958 DOI: 10.1097/NMD.0000000000000698  0.68
2017 Yeung AS, Feng R, Kim DJH, Wayne PM, Yeh GY, Baer L, Lee OE, Denninger JW, Benson H, Fricchione GL, Alpert J, Fava M. A Pilot, Randomized Controlled Study of Tai Chi With Passive and Active Controls in the Treatment of Depressed Chinese Americans. The Journal of Clinical Psychiatry. 78: e522-e528. PMID 28570792 DOI: 10.4088/Jcp.16M10772  0.56
2017 Kim K, Lee H, Hong JP, Cho MJ, Fava M, Mischoulon D, Kim DJ, Jeon HJ. Poor sleep quality and suicide attempt among adults with internet addiction: A nationwide community sample of Korea. Plos One. 12: e0174619. PMID 28384238 DOI: 10.1371/journal.pone.0174619  0.68
2017 de Jong M, Peeters F, Gard T, Ashih H, Doorley J, Walker R, Rhoades L, Kulich RJ, Kueppenbender KD, Alpert JE, Hoge EA, Britton WB, Lazar SW, Fava M, Mischoulon D. A Randomized Controlled Pilot Study on Mindfulness-Based Cognitive Therapy for Unipolar Depression in Patients With Chronic Pain. The Journal of Clinical Psychiatry. PMID 28252881 DOI: 10.4088/Jcp.15M10160  0.88
2017 Freeman MP, Pooley J, Flynn MJ, Baer L, Mischoulon D, Mou D, Fava M. Guarding the Gate: Remote Structured Assessments to Enhance Enrollment Precision in Depression Trials. Journal of Clinical Psychopharmacology. PMID 28187008 DOI: 10.1097/JCP.0000000000000669  0.68
2017 Baek JH, Kim JH, Kim BN, Park SJ, Fava M, Mischoulon D, Lee D, Jeon HJ. Comparisons of Subthreshold Versus Full Posttraumatic Stress Disorder Distinguished by Subjective Functional Impairment Among Train Drivers: A Population-Based Nationwide Study in South Korea. Psychiatry Investigation. 14: 1-7. PMID 28096868 DOI: 10.4306/pi.2017.14.1.1  0.68
2016 Heo JY, Kim K, Fava M, Mischoulon D, Papakostas GI, Kim MJ, Kim DJ, Chang KJ, Oh Y, Yu BH, Jeon HJ. Effects of smartphone use with and without blue light at night in healthy adults: A randomized, double-blind, cross-over, placebo-controlled comparison. Journal of Psychiatric Research. 87: 61-70. PMID 28017916 DOI: 10.1016/j.jpsychires.2016.12.010  0.68
2016 Jeon HJ, Woo JM, Kim HJ, Fava M, Mischoulon D, Cho SJ, Chang SM, Park DH, Kim JW, Yoo I, Heo JY, Hong JP. Gender Differences in Somatic Symptoms and Current Suicidal Risk in Outpatients with Major Depressive Disorder. Psychiatry Investigation. 13: 609-615. PMID 27909451 DOI: 10.4306/pi.2016.13.6.609  0.68
2016 Mischoulon D, Shelton RC, Baer L, Bobo WV, Curren L, Fava M, Papakostas GI. Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Cardiac, Endocrine, Metabolic, and Motoric Effects in a Randomized, Double-Blind, Placebo-Controlled Study. The Journal of Clinical Psychiatry. PMID 27835715 DOI: 10.4088/JCP.15m10426  0.68
2016 Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Soskin DP, Fava M. Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants. Journal of Affective Disorders. 208: 6-14. PMID 27736689 DOI: 10.1016/J.Jad.2016.08.029  0.88
2016 Ma Y, Yeung A, Yang AC, Peng CK, Clain A, Alpert J, Fava M, Yeung AS. The Effects of Tai Chi on Sleep Quality in Chinese American Patients With Major Depressive Disorder: A Pilot Study. Behavioral Sleep Medicine. 1-17. PMID 27676270 DOI: 10.1080/15402002.2016.1228643  0.88
2016 Chen JA, Shapero BG, Trinh NT, Chang TE, Parkin S, Alpert JE, Fava M, Yeung AS. Association Between Stigma and Depression Outcomes Among Chinese Immigrants in a Primary Care Setting. The Journal of Clinical Psychiatry. PMID 27631145 DOI: 10.4088/Jcp.15M10225  0.88
2016 Harper DG, Jensen JE, Ravichandran C, Perlis RH, Fava M, Renshaw PF, Iosifescu DV. Tissue Type Specific Bioenergetic Abnormalities in Adults with Major Depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27585738 DOI: 10.1038/Npp.2016.180  0.44
2016 Yeung A, Martinson MA, Baer L, Chen J, Clain A, Williams A, Chang TE, Trinh NT, Alpert JE, Fava M. The Effectiveness of Telepsychiatry-Based Culturally Sensitive Collaborative Treatment for Depressed Chinese American Immigrants: A Randomized Controlled Trial. The Journal of Clinical Psychiatry. 77: e996-e1002. PMID 27561153 DOI: 10.4088/Jcp.15M09952  0.88
2016 Harel EV, Tennyson RL, Fava M, Bar M. Linking major depression and the neural substrates of associative processing. Cognitive, Affective & Behavioral Neuroscience. PMID 27553369 DOI: 10.3758/s13415-016-0449-9  0.32
2016 Chang KJ, Kim K, Fava M, Mischoulon D, Hong JP, Kim DJ, Heo JY, Choi H, Jeon HJ. Cross-national differences in hypochondriasis symptoms between Korean and American outpatients with major depressive disorder. Psychiatry Research. 245: 127-132. PMID 27541348 DOI: 10.1016/j.psychres.2016.08.019  0.88
2016 Mischoulon D, Zajecka J, Freeman MP, Fava M. Does folic acid interfere with lamotrigine? The Lancet. Psychiatry. 3: 704-705. PMID 27475760 DOI: 10.1016/S2215-0366(16)30167-5  0.68
2016 Yoo HJ, Hong JP, Cho MJ, Fava M, Mischoulon D, Heo JY, Kim K, Jeon HJ. Lifetime suicidal ideation and attempt in adults with full major depressive disorder versus sustained depressed mood. Journal of Affective Disorders. 203: 275-280. PMID 27314814 DOI: 10.1016/j.jad.2016.06.007  0.88
2016 Cassano P, Bui E, Rogers AH, Walton ZE, Ross R, Zeng M, Nadal-Vicens M, Mischoulon D, Baker AW, Keshaviah A, Worthington J, Hoge EA, Alpert J, Fava M, Wong KK, et al. Inflammatory cytokines in major depressive disorder: A case-control study. The Australian and New Zealand Journal of Psychiatry. PMID 27313138 DOI: 10.1177/0004867416652736  0.68
2016 Ionescu DF, Shelton RC, Baer L, Meade KH, Swee MB, Fava M, Papakostas GI. Ziprasidone augmentation for anxious depression. International Clinical Psychopharmacology. PMID 27306192 DOI: 10.1097/YIC.0000000000000133  0.64
2016 Myung W, Han CE, Fava M, Mischoulon D, Papakostas GI, Heo JY, Kim KW, Kim ST, Kim DJ, Kim DK, Seo SW, Seong JK, Jeon HJ. Reduced frontal-subcortical white matter connectivity in association with suicidal ideation in major depressive disorder. Translational Psychiatry. 6: e835. PMID 27271861 DOI: 10.1038/Tp.2016.110  0.68
2016 Papakostas GI, Martinson MA, Fava M, Iovieno N. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression. The Journal of Clinical Psychiatry. 77: e619-24. PMID 27249092 DOI: 10.4088/JCP.14r09767  0.64
2016 Baek JH, Kim HJ, Fava M, Mischoulon D, Papakostas GI, Nierenberg A, Heo JY, Jeon HJ. Reduced Venous Blood Basophil Count and Anxious Depression in Patients with Major Depressive Disorder. Psychiatry Investigation. 13: 321-6. PMID 27247599 DOI: 10.4306/pi.2016.13.3.321  0.88
2016 Ionescu DF, Swee MB, Pavone KJ, Taylor N, Akeju O, Baer L, Nyer M, Cassano P, Mischoulon D, Alpert JE, Brown EN, Nock MK, Fava M, Cusin C. Rapid and sustained reductions in current suicidal ideation following repeated doses of intravenous ketamine: secondary analysis of an open-label study. The Journal of Clinical Psychiatry. PMID 27232360 DOI: 10.4088/Jcp.15M10056  0.88
2016 Sarris J, Murphy J, Mischoulon D, Papakostas GI, Fava M, Berk M, Ng CH. Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses. The American Journal of Psychiatry. appiajp201615091228. PMID 27113121 DOI: 10.1176/Appi.Ajp.2016.15091228  0.68
2016 Otto MW, Lee J, Hofmann SG, Hearon BA, Smits JA, Rosenfield D, Fava M, Wright JH. Examining the Efficacy of D-cycloserine to Augment Therapeutic Learning in Depression. Contemporary Clinical Trials. PMID 27094721 DOI: 10.1016/J.Cct.2016.03.009  0.88
2016 Durgam S, Earley W, Guo H, Li D, Németh G, Laszlovszky I, Fava M, Montgomery SA. Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder. The Journal of Clinical Psychiatry. 77: 371-8. PMID 27046309 DOI: 10.4088/JCP.15m10070  0.88
2016 Trivedi MH, McGrath PJ, Fava M, Parsey RV, Kurian BT, Phillips ML, Oquendo MA, Bruder G, Pizzagalli D, Toups M, Cooper C, Adams P, Weyandt S, Morris DW, Grannemann BD, et al. Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design. Journal of Psychiatric Research. 78: 11-23. PMID 27038550 DOI: 10.1016/J.Jpsychires.2016.03.001  0.88
2016 Zajecka JM, Fava M, Shelton RC, Barrentine LW, Young P, Papakostas GI. Long-term efficacy, safety, and tolerability of L-methylfolate calcium 15 mg as adjunctive therapy with selective serotonin reuptake inhibitors: a 12-month, open-label study following a placebo-controlled acute study. The Journal of Clinical Psychiatry. PMID 27035404 DOI: 10.4088/JCP.15m10181  0.88
2016 Petryshen TL, Lewis MC, Dennehy KA, Garza JC, Fava M. Antidepressant-like effect of low dose ketamine and scopolamine co-treatment in mice. Neuroscience Letters. 620: 70-73. PMID 27033002 DOI: 10.1016/j.neulet.2016.03.051  0.88
2016 Cusin C, Ionescu DF, Pavone KJ, Akeju O, Cassano P, Taylor N, Eikermann M, Durham K, Swee MB, Chang T, Dording C, Soskin D, Kelley J, Mischoulon D, Brown EN, ... Fava M, et al. Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation. The Australian and New Zealand Journal of Psychiatry. PMID 26893373 DOI: 10.1177/0004867416631828  0.68
2016 Fava M, Memisoglu A, Thase ME, Bodkin JA, Trivedi MH, de Somer M, Du Y, Leigh-Pemberton R, DiPetrillo L, Silverman B, Ehrich E. Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial. The American Journal of Psychiatry. appiajp201515070921. PMID 26869247 DOI: 10.1176/appi.ajp.2015.15070921  0.88
2016 Huz I, Nyer M, Dickson C, Farabaugh A, Alpert J, Fava M, Baer L. Obsessive-Compulsive Symptoms as a Risk Factor for Suicidality in U.S. College Students. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. PMID 26803200 DOI: 10.1016/J.Jadohealth.2015.11.011  0.88
2016 Yoo HJ, Hong JP, Cho MJ, Fava M, Mischoulon D, Heo JY, Kim K, Jeon HJ. PS281. Lifetime suicidal ideation and attempt in community adults with full major depressive disorder versus only sustained depressed mood The International Journal of Neuropsychopharmacology. 19: 101-102. DOI: 10.1093/Ijnp/Pyw043.281  0.68
2016 Simon NM, Walton ZE, Bui E, Prescott J, Hoge E, Keshaviah A, Schwarz N, Dryman T, Ojserkis RA, Kovachy B, Mischoulon D, Worthington J, DeVivo I, Fava M, Wong KK. Corrigendum to "Telomere length and telomerase in a well-characterized sample of individuals with major depressive disorder compared to controls" [Psychoneuroendocrinology 58, (2015), 9-22] Psychoneuroendocrinology. 63: 411. DOI: 10.1016/J.Psyneuen.2015.05.010  0.68
2015 Iovieno N, Nierenberg AA, Parkin SR, Hyung Kim DJ, Walker RS, Fava M, Papakostas GI. Relationship between placebo response rate and clinical trial outcome in bipolar depression. Journal of Psychiatric Research. 74: 38-44. PMID 26736040 DOI: 10.1016/j.jpsychires.2015.12.016  0.88
2015 Baer L, Trivedi MH, Huz I, Rush AJ, Wisniewski SR, Fava M. Prevalence and impact of obsessive-compulsive symptoms in depression: a STAR*D report. The Journal of Clinical Psychiatry. 76: 1668-74. PMID 26717526 DOI: 10.4088/Jcp.14M09670  0.88
2015 Kim K, Hong JP, Cho MJ, Fava M, Mischoulon D, Lee DW, Heo JY, Jeon HJ. Loss of sexual interest and premenstrual mood change in women with postpartum versus non-postpartum depression: A nationwide community sample of Korean adults. Journal of Affective Disorders. 191: 222-229. PMID 26682491 DOI: 10.1016/j.jad.2015.11.050  0.88
2015 Fava M, Johe K, Ereshefsky L, Gertsik LG, English BA, Bilello JA, Thurmond LM, Johnstone J, Dickerson BC, Makris N, Hoeppner BB, Flynn M, Mischoulon D, Kinrys G, Freeman MP. A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients. Molecular Psychiatry. PMID 26643541 DOI: 10.1038/Mp.2015.178  0.68
2015 Shelton RC, Pencina MJ, Barrentine LW, Ruiz JA, Fava M, Zajecka JM, Papakostas GI. Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs. The Journal of Clinical Psychiatry. PMID 26613389 DOI: 10.4088/Jcp.14M09587  0.88
2015 Olvet DM, Delaparte L, Yeh FC, DeLorenzo C, McGrath PJ, Weissman MM, Adams P, Fava M, Deckersbach T, McInnis MG, Carmody TJ, Cooper CM, Kurian BT, Lu H, Toups MS, et al. A COMPREHENSIVE EXAMINATION OF WHITE MATTER TRACTS AND CONNECTOMETRY IN MAJOR DEPRESSIVE DISORDER. Depression and Anxiety. PMID 26477532 DOI: 10.7490/F1000Research.1098090.1  0.88
2015 Brennan FX, Gardner KR, Lombard J, Perlis RH, Fava M, Harris HW, Scott R. A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders. The Primary Care Companion For Cns Disorders. 17. PMID 26445691 DOI: 10.4088/Pcc.14M01717  0.88
2015 Mischoulon D, De Jong MF, Vitolo OV, Cusin C, Dording CM, Yeung AS, Durham K, Parkin SR, Fava M, Dougherty DD. Efficacy and safety of a form of cranial electrical stimulation (CES) as an add-on intervention for treatment-resistant major depressive disorder: A three week double blind pilot study. Journal of Psychiatric Research. 70: 98-105. PMID 26424428 DOI: 10.1016/j.jpsychires.2015.08.016  0.88
2015 Shelton RC, Falola M, Li L, Zajecka J, Fava M, Papakostas GI. The pro-inflammatory profile of depressed patients is (partly) related to obesity. Journal of Psychiatric Research. 70: 91-97. PMID 26424427 DOI: 10.1016/j.jpsychires.2015.09.001  0.88
2015 Fava M. Implications of a Biosignature Study of the Placebo Response in Major Depressive Disorder. Jama Psychiatry. 72: 1073-4. PMID 26421499 DOI: 10.1001/jamapsychiatry.2015.1727  0.88
2015 Fava M. The role of regulators, investigators, and patient participants in the rise of the placebo response in major depressive disorder. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 14: 307-8. PMID 26407784 DOI: 10.1002/wps.20247  0.88
2015 Cassano P, Cusin C, Mischoulon D, Hamblin MR, De Taboada L, Pisoni A, Chang T, Yeung A, Ionescu DF, Petrie SR, Nierenberg AA, Fava M, Iosifescu DV. Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study. Psychiatry Journal. 2015: 352979. PMID 26356811 DOI: 10.1155/2015/352979  0.68
2015 Fisher LB, Fava M, Doros GD, Alpert JE, Henry M, Huz I, Freeman MP. The Role of Anger/Hostility in Treatment-Resistant Depression: A Secondary Analysis From the ADAPT-A Study. The Journal of Nervous and Mental Disease. 203: 762-8. PMID 26348584 DOI: 10.1097/Nmd.0000000000000364  0.88
2015 Baek JH, Heo JY, Fava M, Mischoulon D, Nierenberg A, Hong JP, Roh S, Jeon HJ. Anxiety symptoms are linked to new-onset suicidal ideation after six months of follow-up in outpatients with major depressive disorder. Journal of Affective Disorders. 187: 183-7. PMID 26342171 DOI: 10.1016/j.jad.2015.08.006  0.88
2015 Trinh NH, Hails K, Flaherty K, Chang T, Fava M, Yeung A. Lessons Learned: Implementation of a Culturally Focused Psychiatric Consultation Service for Latino Americans and Asian Americans. Journal of Health Care For the Poor and Underserved. 26: 792-801. PMID 26320914 DOI: 10.1353/hpu.2015.0096  0.56
2015 Baek JH, Park JI, Ahn J, Roh SW, Heo JY, Fava M, Mischoulon D, Jeon HJ. Review of Suicide Prevention Programs: Massachusetts, United States, in Comparison with Seoul. Psychiatry Investigation. 12: 281-7. PMID 26207119 DOI: 10.4306/pi.2015.12.3.281  0.88
2015 Greenberg T, Chase HW, Almeida JR, Stiffler R, Zevallos CR, Aslam HA, Deckersbach T, Weyandt S, Cooper C, Toups M, Carmody T, Kurian B, Peltier S, Adams P, McInnis MG, ... ... Fava M, et al. Moderation of the Relationship Between Reward Expectancy and Prediction Error-Related Ventral Striatal Reactivity by Anhedonia in Unmedicated Major Depressive Disorder: Findings From the EMBARC Study. The American Journal of Psychiatry. 172: 881-91. PMID 26183698 DOI: 10.1176/Appi.Ajp.2015.14050594  0.88
2015 Yoo I, Woo JM, Lee SH, Fava M, Mischoulon D, Papakostas GI, Kim EJ, Chung S, Ha JH, Jeon HJ. Influence of anxiety symptoms on improvement of neurocognitive functions in patients with major depressive disorder: A 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study. Journal of Affective Disorders. 185: 24-30. PMID 26142691 DOI: 10.1016/j.jad.2015.06.038  0.88
2015 Goldberg JF, Freeman MP, Balon R, Citrome L, Thase ME, Kane JM, Fava M. THE AMERICAN SOCIETY OF CLINICAL PSYCHOPHARMACOLOGY SURVEY OF PSYCHOPHARMACOLOGISTS' PRACTICE PATTERNS FOR THE TREATMENT OF MOOD DISORDERS. Depression and Anxiety. 32: 605-13. PMID 26129956 DOI: 10.1002/da.22378  0.88
2015 Papakostas GI, Fava M, Baer L, Swee MB, Jaeger A, Bobo WV, Shelton RC. Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study. The American Journal of Psychiatry. appiajp201514101251. PMID 26085041 DOI: 10.1176/appi.ajp.2015.14101251  0.88
2015 Webb CA, Dillon DG, Pechtel P, Goer FK, Murray L, Huys QJ, Fava M, McGrath PJ, Weissman M, Parsey R, Kurian BT, Adams P, Weyandt S, Trombello JM, Grannemann B, et al. Neural Correlates of Three Promising Endophenotypes of Depression: Evidence from the EMBARC Study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26068725 DOI: 10.1038/Npp.2015.165  0.88
2015 Myung W, Lee GH, Won HH, Fava M, Mischoulon D, Nyer M, Kim DK, Heo JY, Jeon HJ. Paraquat prohibition and change in the suicide rate and methods in South Korea. Plos One. 10: e0128980. PMID 26035175 DOI: 10.1371/Journal.Pone.0128980  0.88
2015 Iscan Z, Jin TB, Kendrick A, Szeglin B, Lu H, Trivedi M, Fava M, McGrath PJ, Weissman M, Kurian BT, Adams P, Weyandt S, Toups M, Carmody T, McInnis M, et al. Test-retest reliability of freesurfer measurements within and between sites: Effects of visual approval process. Human Brain Mapping. PMID 26033168 DOI: 10.1002/Hbm.22856  0.88
2015 Targum SD, Wedel PC, Fava M. Changes in cognitive symptoms after a buspirone-melatonin combination treatment for Major Depressive Disorder. Journal of Psychiatric Research. 68: 392-6. PMID 26025562 DOI: 10.1016/j.jpsychires.2015.04.024  0.88
2015 Sarris J, Price LH, Carpenter LL, Tyrka AR, Ng CH, Papakostas GI, Jaeger A, Fava M, Mischoulon D. Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial. Pharmacopsychiatry. 48: 141-4. PMID 26011569 DOI: 10.1055/S-0035-1549928  0.88
2015 Chase HW, Fournier JC, Greenberg T, Almeida JR, Stiffler R, Zevallos CR, Aslam H, Cooper C, Deckersbach T, Weyandt S, Adams P, Toups M, Carmody T, Oquendo MA, Peltier S, ... Fava M, et al. Accounting for Dynamic Fluctuations across Time when Examining fMRI Test-Retest Reliability: Analysis of a Reward Paradigm in the EMBARC Study. Plos One. 10: e0126326. PMID 25961712 DOI: 10.1371/Journal.Pone.0126326  0.88
2015 Farabaugh A, Fisher L, Nyer M, Holt D, Cohen M, Baer L, Shapero BG, Huz I, Cardoos A, Fava M, Alpert JE. Similar changes in cognitions following cognitive-behavioral therapy or escitalopram for major depressive disorder: Implications for mechanisms of change. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 27: 118-26. PMID 25954938  0.88
2015 Nyer M, Mischoulon D, Alpert JE, Holt DJ, Brill CD, Yeung A, Pedrelli P, Baer L, Dording C, Huz I, Fisher L, Fava M, Farabaugh A. College students with depressive symptoms with and without fatigue: Differences in functioning, suicidality, anxiety, and depressive severity. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 27: 100-8. PMID 25954936  0.88
2015 Dording CM, Schettler PJ, Dalton ED, Parkin SR, Walker RS, Fehling KB, Fava M, Mischoulon D. A double-blind placebo-controlled trial of maca root as treatment for antidepressant-induced sexual dysfunction in women. Evidence-Based Complementary and Alternative Medicine : Ecam. 2015: 949036. PMID 25954318 DOI: 10.1155/2015/949036  0.88
2015 Simon NM, Walton ZE, Bui E, Prescott J, Hoge E, Keshaviah A, Schwarz N, Dryman T, Ojserkis RA, Kovachy B, Mischoulon D, Worthington J, DeVivo I, Fava M, Wong KK. Telomere length and telomerase in a well-characterized sample of individuals with major depressive disorder compared to controls. Psychoneuroendocrinology. 58: 9-22. PMID 25932992 DOI: 10.1016/J.Psyneuen.2015.04.004  0.68
2015 Peyrot WJ, Lee SH, Milaneschi Y, Abdellaoui A, Byrne EM, Esko T, de Geus EJ, Hemani G, Hottenga JJ, Kloiber S, Levinson DF, Lucae S, Martin NG, Medland SE, et al. The association between lower educational attainment and depression owing to shared genetic effects? Results in ~25,000 subjects. Molecular Psychiatry. 20: 735-43. PMID 25917368 DOI: 10.1038/Mp.2015.50  0.88
2015 Gomeni R, Goyal N, Bressolle F, Fava M. A Novel Methodology to Estimate the Treatment Effect in Presence of Highly Variable Placebo Response. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 25895454 DOI: 10.1038/npp.2015.105  0.88
2015 Myung W, Won HH, Fava M, Mischoulon D, Yeung A, Lee D, Kim DK, Jeon HJ. Celebrity suicides and their differential influence on suicides in the general population: a national population-based study in Korea. Psychiatry Investigation. 12: 204-11. PMID 25866521 DOI: 10.4306/pi.2015.12.2.204  0.88
2015 Rybin D, Doros G, Pencina MJ, Fava M. Placebo non-response measure in sequential parallel comparison design studies. Statistics in Medicine. 34: 2281-93. PMID 25865181 DOI: 10.1002/Sim.6494  0.88
2015 Dillon DG, Wiecki T, Pechtel P, Webb C, Goer F, Murray L, Trivedi M, Fava M, McGrath PJ, Weissman M, Parsey R, Kurian B, Adams P, Carmody T, Weyandt S, et al. A computational analysis of flanker interference in depression. Psychological Medicine. 45: 2333-44. PMID 25727375 DOI: 10.1017/S0033291715000276  0.88
2015 Janes AC, Pedrelli P, Whitton AE, Pechtel P, Douglas S, Martinson MA, Huz I, Fava M, Pizzagalli DA, Evins AE. Reward Responsiveness Varies by Smoking Status in Women with a History of Major Depressive Disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1940-6. PMID 25662839 DOI: 10.1038/Npp.2015.43  0.88
2015 Heo JY, Jeon HJ, Fava M, Mischoulon D, Baer L, Clain A, Doorley J, Pisoni A, Papakostas GI. Efficacy of ziprasidone monotherapy in patients with anxious depression: a 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial. Journal of Psychiatric Research. 62: 56-61. PMID 25659187 DOI: 10.1016/j.jpsychires.2015.01.007  0.88
2015 Chen JA, Hung GC, Parkin S, Fava M, Yeung AS. Illness beliefs of Chinese American immigrants with major depressive disorder in a primary care setting. Asian Journal of Psychiatry. 13: 16-22. PMID 25563074 DOI: 10.1016/j.ajp.2014.12.005  0.88
2015 Chen JA, Vijapura S, Papakostas GI, Parkin SR, Kim DJ, Cusin C, Baer L, Clain AJ, Fava M, Mischoulon D. Association between physician beliefs regarding assigned treatment and clinical response: re-analysis of data from the Hypericum Depression Trial Study Group. Asian Journal of Psychiatry. 13: 23-9. PMID 25544195 DOI: 10.1016/j.ajp.2014.12.002  0.88
2015 Ehrich E, Turncliff R, Du Y, Leigh-Pemberton R, Fernandez E, Jones R, Fava M. Evaluation of opioid modulation in major depressive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1448-55. PMID 25518754 DOI: 10.1038/Npp.2014.330  0.88
2015 Nierenberg AA, Østergaard SD, Iovieno N, Walker RS, Fava M, Papakostas GI. Predictors of placebo response in bipolar depression. International Clinical Psychopharmacology. 30: 59-66. PMID 25438027 DOI: 10.1097/YIC.0000000000000058  0.88
2015 Fava M, Ramey T, Pickering E, Kinrys G, Boyer S, Altstiel L. A randomized, double-blind, placebo-controlled phase 2 study of the augmentation of a nicotinic acetylcholine receptor partial agonist in depression: is there a relationship to leptin levels? Journal of Clinical Psychopharmacology. 35: 51-6. PMID 25422883 DOI: 10.1097/JCP.0000000000000245  0.88
2015 Clements CC, Castro VM, Blumenthal SR, Rosenfield HR, Murphy SN, Fava M, Erb JL, Churchill SE, Kaimal AJ, Doyle AE, Robinson EB, Smoller JW, Kohane IS, Perlis RH. Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system. Molecular Psychiatry. 20: 727-34. PMID 25155880 DOI: 10.1038/mp.2014.90  0.88
2015 Treadway MT, Waskom ML, Dillon DG, Holmes AJ, Park MT, Chakravarty MM, Dutra SJ, Polli FE, Iosifescu DV, Fava M, Gabrieli JD, Pizzagalli DA. Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression. Biological Psychiatry. 77: 285-94. PMID 25109665 DOI: 10.1016/J.Biopsych.2014.06.018  0.88
2015 Admon R, Nickerson LD, Dillon DG, Holmes AJ, Bogdan R, Kumar P, Dougherty DD, Iosifescu DV, Mischoulon D, Fava M, Pizzagalli DA. Dissociable cortico-striatal connectivity abnormalities in major depression in response to monetary gains and penalties. Psychological Medicine. 45: 121-31. PMID 25055809 DOI: 10.1017/S0033291714001123  0.88
2015 Shelton R, Pencina M, Barrentine L, Ruiz J, Papakostas G, Zajecka J, Fava M. Association of obesity and levels of Inflammatory markers on treatment outcome with adjunctive L-methylfolate (Deplin) in major depressive disorder patients who are inadequate responders to selective serotonin reuptake Inhibitors F1000research. 6. DOI: 10.7490/F1000Research.1098063.1  0.36
2015 Cassano P, Trinh NH, Chang T, Dey Hazra RO, Baer L, Cardoos A, Fava M, Mischoulon D. Major depressive disorder with psychosis-like symptoms in Latinos: treatment with and without antipsychotic augmentation International Journal of Culture and Mental Health. 8: 137-149. DOI: 10.1080/17542863.2014.907327  0.88
2015 Fletcher K, Parker G, Paterson A, Fava M, Iosifescu D, Pizzagalli DA. Anhedonia in melancholic and non-melancholic depressive disorders Journal of Affective Disorders. 184: 81-88. DOI: 10.1016/j.jad.2015.05.028  0.88
2015 Jeon HJ, Fava M. Novel Study Designs for Clinical Trials in Mood Disorders Clinical Trial Design Challenges in Mood Disorders. 87-104. DOI: 10.1016/B978-0-12-405170-6.00008-7  0.88
2015 Farabaugh A, Nyer M, Holt D, Baer L, Petrie S, DiPierro M, Nierenberg A, Pedrelli P, Cusin C, Fava M, Mischoulon D. Screening for Suicide Risk in the College Population Journal of Rational - Emotive and Cognitive - Behavior Therapy. 33: 78-94. DOI: 10.1007/S10942-014-0203-6  0.88
2015 Trinh NH, Hails K, Flaherty K, Chang T, Fava M, Yeung A. Lessons learned: Implementation of a culturally focused psychiatric consultation service for Latino Americans and Asian Americans Journal of Health Care For the Poor and Underserved. 26: 792-801.  0.88
2014 Mischoulon D, Price LH, Carpenter LL, Tyrka AR, Papakostas GI, Fava M. Dr. Mischoulon and colleagues reply. The Journal of Clinical Psychiatry. 75: e1328-9. PMID 25470103 DOI: 10.4088/Jcp.14Lr09266A  0.88
2014 Baer L, Ball S, Sparks J, Raskin J, Dubé S, Ferguson M, Fava M. Further evidence for the reliability and validity of the Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire (CPFQ). Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 26: 270-80. PMID 25401714  0.88
2014 Jeon HJ, Lee C, Fava M, Mischoulon D, Shim EJ, Heo JY, Choi H, Park JH. Childhood trauma, parental death, and their co-occurrence in relation to current suicidality risk in adults: a nationwide community sample of Korea. The Journal of Nervous and Mental Disease. 202: 870-6. PMID 25370752 DOI: 10.1097/NMD.0000000000000217  0.88
2014 Fagerness J, Fonseca E, Hess GP, Scott R, Gardner KR, Koffler M, Fava M, Perlis R, Brennan FX, Lombard J. Pharmacogenetic-guided psychiatric intervention associated with increased adherence and cost savings. The American Journal of Managed Care. 20: e146-56. PMID 25326929  0.88
2014 Jeon HJ, Kim JH, Kim BN, Park SJ, Fava M, Mischoulon D, Kang EH, Roh S, Lee D. Sleep quality, posttraumatic stress, depression, and human errors in train drivers: a population-based nationwide study in South Korea. Sleep. 37: 1969-75. PMID 25325495 DOI: 10.5665/sleep.4252  0.88
2014 Roffman JL, Witte JM, Tanner AS, Ghaznavi S, Abernethy RS, Crain LD, Giulino PU, Lable I, Levy RA, Dougherty DD, Evans KC, Fava M. Neural predictors of successful brief psychodynamic psychotherapy for persistent depression. Psychotherapy and Psychosomatics. 83: 364-70. PMID 25323387 DOI: 10.1159/000364906  0.88
2014 Thase ME, Fava M, Nierenberg AA. Depression: addressing partial response after first-line antidepressant treatment. The Journal of Clinical Psychiatry. 75: 978-80. PMID 25295423 DOI: 10.4088/JCP.13018co4c  0.88
2014 Pedrelli P, Blais MA, Alpert JE, Shelton RC, Walker RS, Fava M. Reliability and validity of the Symptoms of Depression Questionnaire (SDQ). Cns Spectrums. 19: 535-46. PMID 25275853 DOI: 10.1017/S1092852914000406  0.88
2014 Østergaard SD, Fava M, Rothschild AJ, Deligiannidis KM. The implications of the National Institute of Mental Health Research Domain Criteria for researchers and clinicians. Acta Psychiatrica Scandinavica. 130: 409-14. PMID 25201294 DOI: 10.1111/acps.12331  0.88
2014 Yeung A, Slipp LE, Niles H, Jacquart J, Chow CL, Fava M, Denninger JW, Benson H, Fricchione GL. Effectiveness of the relaxation response-based group intervention for treating depressed chinese american immigrants: a pilot study. International Journal of Environmental Research and Public Health. 11: 9186-201. PMID 25198683 DOI: 10.3390/Ijerph110909186  0.88
2014 Baek JH, Kang ES, Fava M, Mischoulon D, Nierenberg AA, Lee D, Heo JY, Jeon HJ. Thyroid stimulating hormone and serum, plasma, and platelet brain-derived neurotrophic factor during a 3-month follow-up in patients with major depressive disorder. Journal of Affective Disorders. 169: 112-7. PMID 25189990 DOI: 10.1016/j.jad.2014.08.009  0.88
2014 Chang TE, Weiss AP, Marques L, Baer L, Vogeli C, Trinh HT, Clain AJ, Blais MA, Fava M, Yeung AS. Race/ethnicity and other social determinants of psychological well-being and functioning in mental health clinics. Journal of Health Care For the Poor and Underserved. 25: 1418-31. PMID 25130249 DOI: 10.1353/Hpu.2014.0138  0.88
2014 Calabrese JR, Fava M, Garibaldi G, Grunze H, Krystal AD, Laughren T, Macfadden W, Marin R, Nierenberg AA, Tohen M. Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders. Journal of Affective Disorders. 168: 439-51. PMID 25113957 DOI: 10.1016/j.jad.2014.06.056  0.88
2014 Chang TE, Jing Y, Yeung AS, Brenneman SK, Kalsekar ID, Hebden T, McQuade RD, Baer L, Kurlander JL, Watkins AK, Siebenaler JA, Fava M. Depression monitoring and patient behavior in the Clinical Outcomes in MEasurement-Based Treatment (COMET) trial. Psychiatric Services (Washington, D.C.). 65: 1058-61. PMID 25082605 DOI: 10.1176/appi.ps.201300326  0.88
2014 Wardenaar KJ, van Loo HM, Cai T, Fava M, Gruber MJ, Li J, de Jonge P, Nierenberg AA, Petukhova MV, Rose S, Sampson NA, Schoevers RA, Wilcox MA, Alonso J, Bromet EJ, et al. The effects of co-morbidity in defining major depression subtypes associated with long-term course and severity. Psychological Medicine. 44: 3289-302. PMID 25066141 DOI: 10.1017/S0033291714000993  0.88
2014 Liverant GI, Sloan DM, Pizzagalli DA, Harte CB, Kamholz BW, Rosebrock LE, Cohen AL, Fava M, Kaplan GB. Associations among smoking, anhedonia, and reward learning in depression. Behavior Therapy. 45: 651-63. PMID 25022776 DOI: 10.1016/J.Beth.2014.02.004  0.88
2014 Targum SD, Burch DJ, Asgharnejad M, Petersen T, Gomeni R, Fava M. Use of band-pass filter analysis to evaluate outcomes in an antidepressant trial for treatment resistant patients. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1188-95. PMID 25012515 DOI: 10.1016/J.Euroneuro.2014.06.003  0.88
2014 Jeon HJ, Park JI, Fava M, Mischoulon D, Sohn JH, Seong S, Park JE, Yoo I, Cho MJ. Feelings of worthlessness, traumatic experience, and their comorbidity in relation to lifetime suicide attempt in community adults with major depressive disorder. Journal of Affective Disorders. 166: 206-12. PMID 25012433 DOI: 10.1016/j.jad.2014.05.010  0.88
2014 Blumenthal SR, Castro VM, Clements CC, Rosenfield HR, Murphy SN, Fava M, Weilburg JB, Erb JL, Churchill SE, Kohane IS, Smoller JW, Perlis RH. An electronic health records study of long-term weight gain following antidepressant use. Jama Psychiatry. 71: 889-96. PMID 24898363 DOI: 10.1001/jamapsychiatry.2014.414  0.88
2014 Sarris J, Papakostas GI, Vitolo O, Fava M, Mischoulon D. S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of response. Journal of Affective Disorders. 164: 76-81. PMID 24856557 DOI: 10.1016/j.jad.2014.03.041  0.88
2014 Ostergaard SD, Bech P, Trivedi MH, Wisniewski SR, Rush AJ, Fava M. Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: implications for the research domain criteria (RDoC). Journal of Affective Disorders. 163: 18-24. PMID 24836083 DOI: 10.1016/J.Jad.2014.03.049  0.88
2014 Jeon HJ, Fava M, Mischoulon D, Baer L, Clain A, Doorley J, DiPierro M, Cardoos A, Papakostas GI. Psychomotor symptoms and treatment outcomes of ziprasidone monotherapy in patients with major depressive disorder: a 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial. International Clinical Psychopharmacology. 29: 332-8. PMID 24815673 DOI: 10.1097/YIC.0000000000000039  0.88
2014 Papakostas GI, Shelton RC, Zajecka JM, Bottiglieri T, Roffman J, Cassiello C, Stahl SM, Fava M. Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial. The Journal of Clinical Psychiatry. 75: 855-63. PMID 24813065 DOI: 10.4088/Jcp.13M08947  0.88
2014 Williams A, Larocca R, Chang T, Trinh NH, Fava M, Kvedar J, Yeung A. Web-based depression screening and psychiatric consultation for college students: a feasibility and acceptability study. International Journal of Telemedicine and Applications. 2014: 580786. PMID 24799895 DOI: 10.1155/2014/580786  0.88
2014 O'Dushlaine C, Ripke S, Ruderfer DM, Hamilton SP, Fava M, Iosifescu DV, Kohane IS, Churchill SE, Castro VM, Clements CC, Blumenthal SR, Murphy SN, Smoller JW, Perlis RH. Rare copy number variation in treatment-resistant major depressive disorder. Biological Psychiatry. 76: 536-41. PMID 24529801 DOI: 10.1016/j.biopsych.2013.10.028  0.88
2014 Jeon HJ, Woo JM, Lee SH, Kim EJ, Chung S, Ha JH, Fava M, Mischoulon D, Kim JH, Heo JY, Yu BH. Improvement in subjective and objective neurocognitive functions in patients with major depressive disorder: a 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study. Journal of Clinical Psychopharmacology. 34: 218-25. PMID 24525660 DOI: 10.1097/JCP.0000000000000072  0.88
2014 Fava M. Assessing response to treatment and recognizing residual depressive symptoms. The Journal of Clinical Psychiatry. 75: e01. PMID 24502864 DOI: 10.4088/JCP.13018tx2c  0.88
2014 Mischoulon D, Price LH, Carpenter LL, Tyrka AR, Papakostas GI, Baer L, Dording CM, Clain AJ, Durham K, Walker R, Ludington E, Fava M. A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder. The Journal of Clinical Psychiatry. 75: 370-6. PMID 24500245 DOI: 10.4088/Jcp.13M08591  0.88
2014 Baek JH, Kang ES, Fava M, Mischoulon D, Nierenberg AA, Yu BH, Lee D, Jeon HJ. Serum lipids, recent suicide attempt and recent suicide status in patients with major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 51: 113-8. PMID 24495778 DOI: 10.1016/j.pnpbp.2014.01.018  0.88
2014 Jeon HJ, Walker RS, Inamori A, Hong JP, Cho MJ, Baer L, Clain A, Fava M, Mischoulon D. Differences in depressive symptoms between Korean and American outpatients with major depressive disorder. International Clinical Psychopharmacology. 29: 150-6. PMID 24323201 DOI: 10.1097/YIC.0000000000000019  0.88
2014 Rothschild AJ, Raskin J, Wang CN, Marangell LB, Fava M. The relationship between change in apathy and changes in cognition and functional outcomes in currently non-depressed SSRI-treated patients with major depressive disorder. Comprehensive Psychiatry. 55: 1-10. PMID 24268564 DOI: 10.1016/j.comppsych.2013.08.008  0.88
2014 Fava M, Ball S, Nelson JC, Sparks J, Konechnik T, Classi P, Dube S, Thase ME. Clinical relevance of fatigue as a residual symptom in major depressive disorder. Depression and Anxiety. 31: 250-7. PMID 24115209 DOI: 10.1002/da.22199  0.88
2014 Trinh NH, Hagan PN, Flaherty K, Traeger LN, Inamori A, Brill CD, Hails K, Chang TE, Bedoya CA, Fava M, Yeung A. Evaluating patient acceptability of a culturally focused psychiatric consultation intervention for Latino Americans with depression. Journal of Immigrant and Minority Health / Center For Minority Public Health. 16: 1271-7. PMID 24097287 DOI: 10.1007/s10903-013-9924-3  0.88
2014 Gomeni R, Fava M. Amyotrophic lateral sclerosis disease progression model. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 15: 119-29. PMID 24070404 DOI: 10.3109/21678421.2013.838970  0.88
2014 Fava M. How can we make measures of psychotic depression symptoms more clinically useful? Acta Psychiatrica Scandinavica. 129: 161-2. PMID 23869739 DOI: 10.1111/acps.12177  0.88
2014 Lu Y, Dipierro M, Chen L, Chin R, Fava M, Yeung A. The evaluation of a culturally appropriate, community-based lifestyle intervention program for elderly Chinese immigrants with chronic diseases: a pilot study. Journal of Public Health (Oxford, England). 36: 149-55. PMID 23596196 DOI: 10.1093/pubmed/fdt037  0.88
2014 Perlis RH, Cusin C, Fava M. Proposed DSM-5 mixed features are associated with greater likelihood of remission in out-patients with major depressive disorder. Psychological Medicine. 44: 1361-7. PMID 22417535 DOI: 10.1017/S0033291712000281  0.88
2014 Hertenstein E, Thiel N, Külz AK, Riemann D, Nissen C, Lüking M, Schramm E, Baglioni C, Spiegelhalder K, Sirois FM, Molnar DS, Phillips KA, Roffman JL, Witte JM, Tanner AS, ... ... Fava M, et al. Contents Vol. 83, 2014 Psychotherapy and Psychosomatics. 83. DOI: 10.1159/000369086  0.44
2013 Pedrelli P, Borsari B, Palm KM, Dalton E, Fava M. Combined MI + CBT for Depressive Symptoms and Binge Drinking Among Young Adults: Two Case Studies. Journal of Cognitive Psychotherapy. 27: 235-257. PMID 25170188 DOI: 10.1891/0889-8391.27.3.235  0.88
2013 Desseilles M, Witte J, Chang TE, Iovieno N, Dording C, Ashih H, Nyer M, Freeman MP, Fava M, Mischoulon D. Massachusetts General Hospital SAFER criteria for clinical trials and research. Harvard Review of Psychiatry. 21: 269-74. PMID 24651559 DOI: 10.1097/Hrp.0B013E3182A75Cc7  0.88
2013 Freeman MP, Walker R, Laughren TP, Miller KK, Fava M. Female reproductive life cycle and hormones: methodology to improve clinical trials. The Journal of Clinical Psychiatry. 74: 1018-21. PMID 24229755 DOI: 10.4088/JCP.13com08742  0.88
2013 Pedrelli P, Nyer M, Holt D, Bakow BR, Fava M, Baer L, Cassiello C, Mulligan M, Cusin C, Farabaugh A. Correlates of irritability in college students with depressive symptoms. The Journal of Nervous and Mental Disease. 201: 953-8. PMID 24177482 DOI: 10.1097/Nmd.0000000000000038  0.88
2013 Toups MS, Myers AK, Wisniewski SR, Kurian B, Morris DW, Rush AJ, Fava M, Trivedi MH. Relationship between obesity and depression: characteristics and treatment outcomes with antidepressant medication. Psychosomatic Medicine. 75: 863-72. PMID 24163386 DOI: 10.1097/Psy.0000000000000000  0.88
2013 Sarris J, Nierenberg AA, Schweitzer I, Alpert JE, Rosenbaum JF, Iovieno N, Covino J, Fava M, Mischoulon D. Conditional probability of response or nonresponse of placebo compared with antidepressants or St John's Wort in major depressive disorder. Journal of Clinical Psychopharmacology. 33: 827-30. PMID 24091858 DOI: 10.1097/Jcp.0B013E31829Cc3Af  0.88
2013 Kim B, Kang ES, Fava M, Mischoulon D, Soskin D, Yu BH, Lee D, Lee DY, Park HD, Jeon HJ. Follicle-stimulating hormone (FSH), current suicidal ideation and attempt in female patients with major depressive disorder. Psychiatry Research. 210: 951-6. PMID 24080256 DOI: 10.1016/j.psychres.2013.08.057  0.88
2013 Cusin C, Iovieno N, Iosifescu DV, Nierenberg AA, Fava M, Rush AJ, Perlis RH. A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder. The Journal of Clinical Psychiatry. 74: e636-41. PMID 23945458 DOI: 10.4088/Jcp.12M08093  0.88
2013 Gilman SE, Breslau J, Trinh NH, Fava M, Murphy JM, Smoller JW. Dr Gilman and colleagues reply. The Journal of Clinical Psychiatry. 74: 741-3. PMID 23945454 DOI: 10.4088/JCP.12lr08310a  0.88
2013 Soskin DP, Holt DJ, Sacco GR, Fava M. Incentive salience: novel treatment strategies for major depression. Cns Spectrums. 18: 307-14. PMID 23903027 DOI: 10.1017/S1092852913000345  0.88
2013 Borsook D, Becerra L, Fava M. Use of functional imaging across clinical phases in CNS drug development. Translational Psychiatry. 3: e282. PMID 23860483 DOI: 10.1038/Tp.2013.43  0.88
2013 Jeon HJ, Hong JP, Fava M, Mischoulon D, Nyer M, Inamori A, Sohn JH, Seong S, Cho MJ. Childhood parental death and lifetime suicide attempt of the opposite-gender offspring in a nationwide community sample of Korea. Suicide & Life-Threatening Behavior. 43: 598-610. PMID 23834109 DOI: 10.1111/Sltb.12042  0.88
2013 Dording C, Cassiello C, King F, Pencina M, Fava M, Mischoulon D. The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression. International Clinical Psychopharmacology. 28: 238-44. PMID 23764521 DOI: 10.1097/Yic.0B013E32836220Df  0.88
2013 Yeung A, Slipp LE, Jacquart J, Fava M, Denninger JW, Benson H, Fricchione GL. The treatment of depressed chinese americans using qigong in a health care setting: a pilot study. Evidence-Based Complementary and Alternative Medicine : Ecam. 2013: 168784. PMID 23690836 DOI: 10.1155/2013/168784  0.88
2013 Nyer M, Farabaugh A, Fehling K, Soskin D, Holt D, Papakostas GI, Pedrelli P, Fava M, Pisoni A, Vitolo O, Mischoulon D. Relationship between sleep disturbance and depression, anxiety, and functioning in college students. Depression and Anxiety. 30: 873-80. PMID 23681944 DOI: 10.1002/Da.22064  0.88
2013 Ratti E, Bettica P, Alexander R, Archer G, Carpenter D, Evoniuk G, Gomeni R, Lawson E, Lopez M, Millns H, Rabiner EA, Trist D, Trower M, Zamuner S, Krishnan R, ... Fava M, et al. Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies. Journal of Psychopharmacology (Oxford, England). 27: 424-34. PMID 23539641 DOI: 10.1177/0269881113480990  0.88
2013 Matthews JD, Siefert CJ, Blais MA, Park LT, Siefert CJ, Welch CA, Dubois CM, van Nieuwenhuizen AO, Rooney KO, Seabrook RC, Durham LE, Adams HC, Fava M. A double-blind, placebo-controlled study of the impact of galantamine on anterograde memory impairment during electroconvulsive therapy. The Journal of Ect. 29: 170-8. PMID 23519225 DOI: 10.1097/YCT.0b013e31828b3523  0.88
2013 Cassano P, Chang T, Trinh NH, Baer L, Fava M, Mischoulon D. Differential impact of isolated psychotic symptoms on treatment outcome of major depressive disorder in the STAR*D cohort of Whites, Blacks and Latinos. Journal of Affective Disorders. 150: 578-84. PMID 23489398 DOI: 10.1016/j.jad.2013.02.012  0.88
2013 Cardoos A, Inamori A, Sanacora G, Fava M, Mischoulon D. Delayed amnesic syndrome after riluzole use in major depressive disorder: a case report. Psychosomatics. 54: 488-92. PMID 23473447 DOI: 10.1016/j.psym.2013.02.002  0.88
2013 Harte CB, Liverant GI, Sloan DM, Kamholz BW, Rosebrock LE, Fava M, Kaplan GB. Association between smoking and heart rate variability among individuals with depression. Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. 46: 73-80. PMID 23436273 DOI: 10.1007/S12160-013-9476-8  0.88
2013 Jeon HJ, Peng D, Chua HC, Srisurapanont M, Fava M, Bae JN, Man Chang S, Hong JP. Melancholic features and hostility are associated with suicidality risk in Asian patients with major depressive disorder. Journal of Affective Disorders. 148: 368-74. PMID 23414572 DOI: 10.1016/j.jad.2013.01.001  0.88
2013 Kornstein SG, Toups M, Rush AJ, Wisniewski SR, Thase ME, Luther J, Warden D, Fava M, Trivedi MH. Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Journal of Women's Health (2002). 22: 121-31. PMID 23398127 DOI: 10.1089/Jwh.2012.3479  0.88
2013 Nyer M, Holt DJ, Pedrelli P, Fava M, Ameral V, Cassiello CF, Nock MK, Ross M, Hutchinson D, Farabaugh A. Factors that distinguish college students with depressive symptoms with and without suicidal thoughts. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 25: 41-9. PMID 23376869  0.88
2013 Dording CM, LaRocca RA, Hails KA, Vitolo OV, Wisniewski SR, Balasubramani GK, Trivedi M, Fava M, Mischoulon D. The effect of sildenafil on quality of life. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 25: 3-10. PMID 23376864  0.88
2013 Castro VM, Clements CC, Murphy SN, Gainer VS, Fava M, Weilburg JB, Erb JL, Churchill SE, Kohane IS, Iosifescu DV, Smoller JW, Perlis RH. QT interval and antidepressant use: a cross sectional study of electronic health records. Bmj (Clinical Research Ed.). 346: f288. PMID 23360890 DOI: 10.1136/bmj.f288  0.88
2013 Doros G, Pencina M, Rybin D, Meisner A, Fava M. A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies. Statistics in Medicine. 32: 2767-89. PMID 23355369 DOI: 10.1002/Sim.5728  0.88
2013 Vitali M, Tedeschini E, Mistretta M, Fehling K, Aceti F, Ceccanti M, Fava M. Adjunctive pregabalin in partial responders with major depressive disorder and residual anxiety. Journal of Clinical Psychopharmacology. 33: 95-8. PMID 23277244 DOI: 10.1097/JCP.0b013e31827b9351  0.88
2013 Pedrelli P, Bentley K, Vitali M, Clain AJ, Nyer M, Fava M, Farabaugh AH. Compulsive use of alcohol among college students. Psychiatry Research. 205: 95-102. PMID 22951374 DOI: 10.1016/J.Psychres.2012.08.012  0.88
2013 Sanchez-Villegas A, Field AE, O'Reilly EJ, Fava M, Gortmaker S, Kawachi I, Ascherio A. Perceived and actual obesity in childhood and adolescence and risk of adult depression. Journal of Epidemiology and Community Health. 67: 81-6. PMID 22766776 DOI: 10.1136/Jech-2012-201435  0.88
2013 Gilman SE, Trinh NH, Smoller JW, Fava M, Murphy JM, Breslau J. Psychosocial stressors and the prognosis of major depression: a test of Axis IV. Psychological Medicine. 43: 303-16. PMID 22640506 DOI: 10.1017/S0033291712001080  0.88
2013 Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM, Breen G, Byrne EM, Blackwood DH, Boomsma DI, Cichon S, Heath AC, Holsboer F, Lucae S, Madden PA, ... ... Fava M, et al. A mega-analysis of genome-wide association studies for major depressive disorder. Molecular Psychiatry. 18: 497-511. PMID 22472876 DOI: 10.1038/Mp.2012.21  0.44
2013 Uher R, Tansey KE, Rietschel M, Henigsberg N, Maier W, Mors O, Hauser J, Placentino A, Souery D, Farmer A, Aitchison KJ, Craig I, McGuffin P, Lewis CM, Ising M, ... ... Fava M, et al. Common genetic variation and antidepressant efficacy in major depressive disorder: A meta-analysis of three genome-wide pharmacogenetic studies American Journal of Psychiatry. 170: 207-217. DOI: 10.1176/Appi.Ajp.2012.12020237  0.88
2013 Youn SJ, Trinh NH, Shyu I, Chang T, Fava M, Kvedar J, Yeung A. Using online social media, Facebook, in screening for major depressive disorder among college students International Journal of Clinical and Health Psychology. 13: 74-80. DOI: 10.1016/S1697-2600(13)70010-3  0.88
2012 Trinh NH, Larocca R, Regan S, Chang TE, Gilman SE, Fava M, Yeung A. Using the Electronic Medical Record to Examine Racial and Ethnic Differences in Depression Diagnosis and Treatment in a Primary Care Population. Primary Health Care : Open Access. 1: 1000106. PMID 24524015 DOI: 10.4172/2167-1079.1000106  0.56
2012 Papakostas GI, Vitolo OV, Ishak WW, Rapaport MH, Zajecka JM, Kinrys G, Mischoulon D, Lipkin SH, Hails KA, Abrams J, Ward SG, Meisner A, Schoenfeld DA, Shelton RC, Winokur A, ... ... Fava M, et al. A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder. The Journal of Clinical Psychiatry. 73: 1541-7. PMID 23290327 DOI: 10.4088/Jcp.12M07670  0.88
2012 Krystal AD, McCall WV, Fava M, Joffe H, Soares CN, Huang H, Grinell T, Zummo J, Spalding W, Marshall R. Eszopiclone treatment for insomnia: effect size comparisons in patients with primary insomnia and insomnia with medical and psychiatric comorbidity. The Primary Care Companion For Cns Disorders. 14. PMID 23251857 DOI: 10.4088/PCC.11m01296  0.88
2012 Papakostas GI, Shelton RC, Zajecka JM, Etemad B, Rickels K, Clain A, Baer L, Dalton ED, Sacco GR, Schoenfeld D, Pencina M, Meisner A, Bottiglieri T, Nelson E, Mischoulon D, ... ... Fava M, et al. L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. The American Journal of Psychiatry. 169: 1267-74. PMID 23212058 DOI: 10.1176/Appi.Ajp.2012.11071114  0.88
2012 Witte J, Bentley K, Evins AE, Clain AJ, Baer L, Pedrelli P, Fava M, Mischoulon D. A randomized, controlled, pilot study of acamprosate added to escitalopram in adults with major depressive disorder and alcohol use disorder. Journal of Clinical Psychopharmacology. 32: 787-96. PMID 23131884 DOI: 10.1097/Jcp.0B013E3182726764  0.88
2012 Gilman SE, Breslau J, Trinh NH, Fava M, Murphy JM, Smoller JW. Epidemiologic evidence concerning the bereavement exclusion in major depression. Archives of General Psychiatry. 69: 1179-80; author repl. PMID 23117639 DOI: 10.1001/archgenpsychiatry.2012.383  0.88
2012 Perlis RH, Uher R, Perroud N, Fava M. Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial? The Journal of Clinical Psychiatry. 73: 1439-42. PMID 23059018 DOI: 10.4088/JCP.12m07777  0.88
2012 Gallagher PJ, Castro V, Fava M, Weilburg JB, Murphy SN, Gainer VS, Churchill SE, Kohane IS, Iosifescu DV, Smoller JW, Perlis RH. Antidepressant response in patients with major depression exposed to NSAIDs: a pharmacovigilance study. The American Journal of Psychiatry. 169: 1065-72. PMID 23032386 DOI: 10.1176/appi.ajp.2012.11091325  0.88
2012 Fava M, Targum SD, Nierenberg AA, Bleicher LS, Carter TA, Wedel PC, Hen R, Gage FH, Barlow C. An exploratory study of combination buspirone and melatonin SR in major depressive disorder (MDD): a possible role for neurogenesis in drug discovery. Journal of Psychiatric Research. 46: 1553-63. PMID 22998742 DOI: 10.1016/J.Jpsychires.2012.08.013  0.64
2012 Nierenberg AA, Bentley KH, Farabaugh AH, Fava M, Deckersbach T. The absence of depressive symptoms is not the presence of wellness: validation of the Clinical Positive Affect Scale. The Australian and New Zealand Journal of Psychiatry. 46: 1165-72. PMID 22990434 DOI: 10.1177/0004867412459810  0.88
2012 Farabaugh A, Alpert J, Wisniewski SR, Otto MW, Fava M, Baer L, Perlis R, Friedman E, Nyer M, Bitran S, Balasubramani GK, Inamori A, Trivedi M, Thase ME. Cognitive therapy for anxious depression in STAR(*) D: what have we learned? Journal of Affective Disorders. 142: 213-8. PMID 22877961 DOI: 10.1016/J.Jad.2012.04.029  0.88
2012 Cusin C, Hilton GQ, Nierenberg AA, Fava M. Long-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depression. The American Journal of Psychiatry. 169: 868-9. PMID 22854933 DOI: 10.1176/appi.ajp.2012.12020219  0.88
2012 Kelley JM, Kaptchuk TJ, Cusin C, Lipkin S, Fava M. Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics. 81: 312-4. PMID 22854752 DOI: 10.1159/000337053  0.88
2012 Yeung A, Feldman G, Pedrelli P, Hails K, Fava M, Reyes T, Mundt JC. The Quick Inventory of Depressive Symptomatology, clinician rated and self-report: a psychometric assessment in Chinese Americans with major depressive disorder. The Journal of Nervous and Mental Disease. 200: 712-5. PMID 22850307 DOI: 10.1097/Nmd.0B013E318261413D  0.88
2012 Yeung AS, Jing Y, Brenneman SK, Chang TE, Baer L, Hebden T, Kalsekar I, McQuade RD, Kurlander J, Siebenaler J, Fava M. Clinical Outcomes in Measurement-based Treatment (Comet): a trial of depression monitoring and feedback to primary care physicians. Depression and Anxiety. 29: 865-73. PMID 22807244 DOI: 10.1002/da.21983  0.88
2012 Yeung A, Lepoutre V, Wayne P, Yeh G, Slipp LE, Fava M, Denninger JW, Benson H, Fricchione GL. Tai chi treatment for depression in Chinese Americans: a pilot study. American Journal of Physical Medicine & Rehabilitation / Association of Academic Physiatrists. 91: 863-70. PMID 22790795 DOI: 10.1097/Phm.0B013E31825F1A67  0.88
2012 Mischoulon D, Lamon-Fava S, Selhub J, Katz J, Papakostas GI, Iosifescu DV, Yeung AS, Dording CM, Farabaugh AH, Clain AJ, Baer L, Alpert JE, Nierenberg AA, Fava M. Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment. Cns Spectrums. 17: 76-86. PMID 22789065 DOI: 10.1017/S1092852912000430  0.88
2012 Mischoulon D, Alpert JE, Arning E, Bottiglieri T, Fava M, Papakostas GI. Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder. The Journal of Clinical Psychiatry. 73: 843-8. PMID 22687580 DOI: 10.4088/Jcp.11M07139  0.88
2012 Sung SC, Haley CL, Wisniewski SR, Fava M, Nierenberg AA, Warden D, Morris DW, Kurian BT, Trivedi MH, Rush AJ. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations. The Journal of Clinical Psychiatry. 73: 967-76. PMID 22687487 DOI: 10.4088/Jcp.11M07043  0.88
2012 Soskin DP, Carl JR, Alpert J, Fava M. Antidepressant effects on emotional temperament: toward a biobehavioral research paradigm for major depressive disorder. Cns Neuroscience & Therapeutics. 18: 441-51. PMID 22672296 DOI: 10.1111/J.1755-5949.2012.00318.X  0.88
2012 Farabaugh A, Bitran S, Nyer M, Holt DJ, Pedrelli P, Shyu I, Hollon SD, Zisook S, Baer L, Busse W, Petersen TJ, Pender M, Tucker DD, Fava M. Depression and suicidal ideation in college students. Psychopathology. 45: 228-34. PMID 22627683 DOI: 10.1159/000331598  0.88
2012 Sarris J, Fava M, Schweitzer I, Mischoulon D. St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT. Pharmacopsychiatry. 45: 275-8. PMID 22592504 DOI: 10.1055/s-0032-1306348  0.88
2012 Hails K, Brill CD, Chang T, Yeung A, Fava M, Trinh NH. Cross-cultural aspects of depression management in primary care. Current Psychiatry Reports. 14: 336-44. PMID 22580834 DOI: 10.1007/s11920-012-0276-9  0.88
2012 Mischoulon D, Brill CD, Ameral VE, Fava M, Yeung AS. A pilot study of acupuncture monotherapy in patients with major depressive disorder. Journal of Affective Disorders. 141: 469-73. PMID 22521855 DOI: 10.1016/j.jad.2012.03.023  0.88
2012 Davis LL, Pilkinton P, Wisniewski SR, Trivedi MH, Gaynes BN, Howland RH, Zisook S, Balasubramani GK, Fava M, Rush AJ. Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial. Depression and Anxiety. 29: 111-22. PMID 22495941 DOI: 10.1002/Da.20918  0.88
2012 Castro VM, Gallagher PJ, Clements CC, Murphy SN, Gainer VS, Fava M, Weilburg JB, Churchill SE, Kohane IS, Iosifescu DV, Smoller JW, Perlis RH. Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants. Bmj Open. 2: e000544. PMID 22466034 DOI: 10.1136/bmjopen-2011-000544  0.88
2012 Cassano P, Fava M, Mischoulon D. Major depressive disorder with psychosis-like symptoms among Latinos. Psychiatric Services (Washington, D.C.). 63: 482-7. PMID 22422016 DOI: 10.1176/appi.ps.201100271  0.88
2012 Fava M, Mischoulon D, Iosifescu D, Witte J, Pencina M, Flynn M, Harper L, Levy M, Rickels K, Pollack M. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). Psychotherapy and Psychosomatics. 81: 87-97. PMID 22286203 DOI: 10.1159/000332050  0.88
2012 Chang TE, Jing Y, Yeung AS, Brenneman SK, Kalsekar I, Hebden T, McQuade R, Baer L, Kurlander JL, Watkins AK, Siebenaler JA, Fava M. Effect of communicating depression severity on physician prescribing patterns: findings from the Clinical Outcomes in MEasurement-based Treatment (COMET) trial. General Hospital Psychiatry. 34: 105-12. PMID 22264654 DOI: 10.1016/j.genhosppsych.2011.12.003  0.88
2012 Targum SD, Hassman H, Pinho M, Fava M. Development of a clinical global impression scale for fatigue. Journal of Psychiatric Research. 46: 370-4. PMID 22236834 DOI: 10.1016/j.jpsychires.2011.12.001  0.88
2012 Dording CM, Dalton ED, Pencina MJ, Fava M, Mischoulon D. Comparison of academic and nonacademic sites in multi-center clinical trials. Journal of Clinical Psychopharmacology. 32: 65-8. PMID 22198440 DOI: 10.1097/Jcp.0B013E31823F3B47  0.88
2012 Gollan JK, Fava M, Kurian B, Wisniewski SR, Rush AJ, Daly E, Miyahara S, Trivedi MH. What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression? Depression and Anxiety. 29: 94-101. PMID 22147631 DOI: 10.1002/Da.20917  0.88
2012 Chan HN, Rush AJ, Nierenberg AA, Trivedi M, Wisniewski SR, Balasubramani GK, Friedman ES, Gaynes BN, Davis L, Morris D, Fava M. Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 1387-99. PMID 22129562 DOI: 10.1017/S1461145711001660  0.88
2012 Bech P, Fava M, Trivedi MH, Wisniewski SR, Rush AJ. Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial. Acta Psychiatrica Scandinavica. 125: 342-8. PMID 22077211 DOI: 10.1111/j.1600-0447.2011.01791.x  0.88
2012 Rush AJ, Wisniewski SR, Zisook S, Fava M, Sung SC, Haley CL, Chan HN, Gilmer WS, Warden D, Nierenberg AA, Balasubramani GK, Gaynes BN, Trivedi MH, Hollon SD. Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report. Psychological Medicine. 42: 1131-49. PMID 22008447 DOI: 10.1017/S0033291711002170  0.88
2012 Mischoulon D, Witte J, Levy M, Papakostas GI, Pet LR, Hsieh WH, Pencina MJ, Ward S, Pollack MH, Fava M. Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial. The Journal of Clinical Psychiatry. 73: 353-7. PMID 21939613 DOI: 10.4088/Jcp.10M06541  0.88
2012 Tran P, Skolnick P, Czobor P, Huang NY, Bradshaw M, McKinney A, Fava M. Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Journal of Psychiatric Research. 46: 64-71. PMID 21925682 DOI: 10.1016/J.Jpsychires.2011.09.003  0.88
2012 Friedman ES, Davis LL, Zisook S, Wisniewski SR, Trivedi MH, Fava M, Rush AJ. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 183-99. PMID 21920711 DOI: 10.1016/J.Euroneuro.2011.07.010  0.88
2012 Gilman SE, Breslau J, Trinh NH, Fava M, Murphy JM, Smoller JW. Bereavement and the diagnosis of major depressive episode in the National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of Clinical Psychiatry. 73: 208-15. PMID 21903020 DOI: 10.4088/JCP.10m06080  0.88
2012 Janes AC, Smoller JW, David SP, Frederick BD, Haddad S, Basu A, Fava M, Evins AE, Kaufman MJ. Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women. Drug and Alcohol Dependence. 120: 7-13. PMID 21764527 DOI: 10.1016/J.Drugalcdep.2011.06.009  0.88
2012 Perlis RH, Iosifescu DV, Castro VM, Murphy SN, Gainer VS, Minnier J, Cai T, Goryachev S, Zeng Q, Gallagher PJ, Fava M, Weilburg JB, Churchill SE, Kohane IS, Smoller JW. Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model. Psychological Medicine. 42: 41-50. PMID 21682950 DOI: 10.1017/S0033291711000997  0.88
2012 Trivedi MH, Rush AJ, Kurian BT, Nierenberg AA, Wisniewski SR, Fava M. Response to Blier letter American Journal of Psychiatry. 169: 95-96. DOI: 10.1176/Appi.Ajp.2011.11071055R  0.88
2012 Fava M, Mischoulon D, Iosifescu D, Witte J, Pencina M, Flynn M, Harper L, Levy M, Rickels K, Pollack M. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A study):(Psychotherapy and Psychosomatics (2012) 81, (87-97)) Psychotherapy and Psychosomatics. 81: 261. DOI: 10.1159/000337702  0.88
2012 Kanayama G, Hudson JI, Pope HG, Oe M, Schnyder U, Schumacher S, Mueller-Pfeiffer C, Wilhelm FH, Kalebasi N, Roos D, Hersberger M, Martin-Soelch C, Fava M, Mischoulon D, Iosifescu D, et al. Front & Back Matter Psychotherapy and Psychosomatics. 81. DOI: 10.1159/000337199  0.68
2012 Kessler RC, Coccaro EF, Fava M, McLaughlin KA. The Phenomenology and Epidemiology of Intermittent Explosive Disorder The Oxford Handbook of Impulse Control Disorders. DOI: 10.1093/oxfordhb/9780195389715.013.0053  0.88
2012 Tran P, Skolnick P, Czobor P, Huang NY, Bradshaw M, McKinney A, Fava M. Response to Marks, Abramowitz, and Spielmans Letter to the Editor Journal of Psychiatric Research. 46: 694-695. DOI: 10.1016/J.Jpsychires.2012.02.001  0.88
2012 Desseilles M, Fava M, Mischoulon D, Freeman MP. The authors respond Current Psychiatry. 11: 9-A.  0.88
2012 Desseilles M, Fava M, Mischoulon D, Freeman MP. Reliable diagnosis, count of adequate antidepressant trials can suggest next steps Current Psychiatry. 11: 26-33.  0.88
2012 Fava M, Abe Y. Fatigue as a core symptom of insomnia Innovations in Clinical Neuroscience. 9: 10-14.  0.88
2011 Yeung A, Trinh NH, Chang TE, Fava M. The Engagement Interview Protocol (EIP): improving the acceptance of mental health treatment among Chinese immigrants. International Journal of Culture and Mental Health. 4: 91-105. PMID 25076983 DOI: 10.1080/17542863.2010.507933  0.56
2011 Zisook S, Lesser IM, Lebowitz B, Rush AJ, Kallenberg G, Wisniewski SR, Nierenberg AA, Fava M, Luther JF, Morris DW, Trivedi MH. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study. The Journal of Clinical Psychiatry. 72: 1322-32. PMID 22075098 DOI: 10.4088/Jcp.10M06724  0.88
2011 McClintock SM, Husain MM, Bernstein IH, Wisniewski SR, Trivedi MH, Morris D, Alpert J, Warden D, Luther JF, Kornstein SG, Biggs MM, Fava M, Rush AJ. Assessing anxious features in depressed outpatients. International Journal of Methods in Psychiatric Research. 20: e69-82. PMID 22057975 DOI: 10.1002/Mpr.353  0.88
2011 Chen JA, Papakostas GI, Youn SJ, Baer L, Clain AJ, Fava M, Mischoulon D. Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study Group. The Journal of Clinical Psychiatry. 72: 1669-76. PMID 22053942 DOI: 10.4088/JCP.10m06453  0.68
2011 Trinh NH, Bedoya CA, Chang TE, Flaherty K, Fava M, Yeung A. A study of a culturally focused psychiatric consultation service for Asian American and Latino American primary care patients with depression. Bmc Psychiatry. 11: 166. PMID 21995514 DOI: 10.1186/1471-244X-11-166  0.88
2011 Lesser IM, Zisook S, Gaynes BN, Wisniewski SR, Luther JF, Fava M, Khan A, McGrath P, Warden D, Rush AJ, Trivedi M. Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial. Psychiatric Services (Washington, D.C.). 62: 1167-79. PMID 21969643 DOI: 10.1176/Ps.62.10.Pss6210_1167  0.88
2011 Denninger JW, van Nieuwenhuizen AO, Wisniewski SR, Luther JF, Trivedi MH, Rush AJ, Gollan JK, Pizzagalli DA, Fava M. Changes in depressive symptoms and social functioning in the sequenced treatment alternatives to relieve depression study. The Journal of Nervous and Mental Disease. 199: 807-10. PMID 21964277 DOI: 10.1097/Nmd.0B013E31822Fcbe2  0.88
2011 Yeung A, Hails K, Chang T, Trinh NH, Fava M. A study of the effectiveness of telepsychiatry-based culturally sensitive collaborative treatment of depressed Chinese Americans. Bmc Psychiatry. 11: 154. PMID 21943315 DOI: 10.1186/1471-244X-11-154  0.88
2011 Desseilles M, Witte J, Chang TE, Iovieno N, Dording CM, Ashih H, Nyer M, Freeman MP, Fava M, Mischoulon D. Assessing the adequacy of past antidepressant trials: a clinician's guide to the antidepressant treatment response questionnaire. The Journal of Clinical Psychiatry. 72: 1152-4. PMID 21899818 DOI: 10.4088/Jcp.11Ac07225  0.88
2011 Evins AE, Pachas G, Mischoulon D, Urbanoski K, Carlini S, Sousa J, Bentley K, Rigotti NA, Nino-Gomez J, Loebl T, Janes AC, Kaufman MJ, Fava M. A double-blind, placebo-controlled trial of the NMDA glycine site antagonist, GW468816, for prevention of relapse to smoking in females. Journal of Clinical Psychopharmacology. 31: 597-602. PMID 21869693 DOI: 10.1097/Jcp.0B013E31822Bb390  0.88
2011 Farabaugh AH, Locascio JJ, Yap L, Fava M, Bitran S, Sousa JL, Growdon JH. Assessing depression and factors possibly associated with depression during the course of Parkinson's disease. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 23: 171-7. PMID 21808748  0.88
2011 Trivedi MH, Wisniewski SR, Morris DW, Fava M, Kurian BT, Gollan JK, Nierenberg AA, Warden D, Gaynes BN, Luther JF, Rush AJ. Concise Associated Symptoms Tracking scale: a brief self-report and clinician rating of symptoms associated with suicidality. The Journal of Clinical Psychiatry. 72: 765-74. PMID 21733477 DOI: 10.4088/Jcp.11M06840  0.88
2011 Trivedi MH, Wisniewski SR, Morris DW, Fava M, Gollan JK, Warden D, Nierenberg AA, Gaynes BN, Husain MM, Luther JF, Zisook S, Rush AJ. Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk. The Journal of Clinical Psychiatry. 72: 757-64. PMID 21733476 DOI: 10.4088/Jcp.11M06837  0.88
2011 Fava M, Dording CM, Baker RA, Mankoski R, Tran QV, Forbes RA, Eudicone JM, Owen R, Berman RM. Effects of adjunctive aripiprazole on sexual functioning in patients with major depressive disorder and an inadequate response to standard antidepressant monotherapy: a post hoc analysis of 3 randomized, double-blind, placebo-controlled studies. The Primary Care Companion For Cns Disorders. 13. PMID 21731833 DOI: 10.4088/PCC.10m00994gre  0.36
2011 Posternak MA, Baer L, Nierenberg AA, Fava M. Response rates to fluoxetine in subjects who initially show no improvement. The Journal of Clinical Psychiatry. 72: 949-54. PMID 21672502 DOI: 10.4088/JCP.10m06098  0.64
2011 Mashhoon Y, Janes AC, Jensen JE, Prescot AP, Pachas G, Renshaw PF, Fava M, Evins AE, Kaufman MJ. Anterior cingulate proton spectroscopy glutamate levels differ as a function of smoking cessation outcome. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 1709-13. PMID 21616118 DOI: 10.1016/J.Pnpbp.2011.05.006  0.88
2011 Bobo WV, Chen H, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Lesser IM, Kornstein SG, Wisniewski SR, et al. Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. Journal of Affective Disorders. 133: 467-76. PMID 21601287 DOI: 10.1016/J.Jad.2011.04.032  0.88
2011 Rush AJ, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Shelton RC, Lesser IM, Kornstein SG, Wisniewski SR. Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. The American Journal of Psychiatry. 168: 689-701. PMID 21536692 DOI: 10.1176/Appi.Ajp.2011.10111645  0.88
2011 Trinh NH, Youn SJ, Sousa J, Regan S, Bedoya CA, Chang TE, Fava M, Yeung A. Using electronic medical records to determine the diagnosis of clinical depression. International Journal of Medical Informatics. 80: 533-40. PMID 21514880 DOI: 10.1016/j.ijmedinf.2011.03.014  0.88
2011 Bech P, Fava M, Trivedi MH, Wisniewski SR, Rush AJ. Factor structure and dimensionality of the two depression scales in STAR*D using level 1 datasets. Journal of Affective Disorders. 132: 396-400. PMID 21440308 DOI: 10.1016/j.jad.2011.03.011  0.88
2011 Trinh NH, Shyu I, McGrath PJ, Clain A, Baer L, Fava M, Yeung A. Examining the role of race and ethnicity in relapse rates of major depressive disorder. Comprehensive Psychiatry. 52: 151-5. PMID 21295221 DOI: 10.1016/j.comppsych.2010.05.004  0.56
2011 Bitran S, Farabaugh AH, Ameral VE, LaRocca RA, Clain AJ, Fava M, Mischoulon D. Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI. International Clinical Psychopharmacology. 26: 206-12. PMID 21278577 DOI: 10.1097/Yic.0B013E328343Ba08  0.88
2011 Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial. The Journal of Clinical Psychiatry. 72: 914-28. PMID 21208597 DOI: 10.4088/JCP.09m05571gry  0.88
2011 Tedeschini E, Fava M, Papakostas GI. Placebo-controlled, antidepressant clinical trials cannot be shortened to less than 4 weeks' duration: a pooled analysis of randomized clinical trials employing a diagnostic odds ratio-based approach. The Journal of Clinical Psychiatry. 72: 98-113. PMID 21208576 DOI: 10.4088/JCP.09m05725blu  0.64
2011 Fava M, Schaefer K, Huang H, Wilson A, Iosifescu DV, Mischoulon D, Wessel TC. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression. The Journal of Clinical Psychiatry. 72: 473-9. PMID 21208574 DOI: 10.4088/JCP.09m05131gry  0.68
2011 Daly EJ, Trivedi MH, Fava M, Shelton R, Wisniewski SR, Morris DW, Stegman D, Preskorn SH, Rush AJ. The relationship between adverse events during selective serotonin reuptake inhibitor treatment for major depressive disorder and nonremission in the suicide assessment methodology study. Journal of Clinical Psychopharmacology. 31: 31-8. PMID 21192140 DOI: 10.1097/Jcp.0B013E318205E17B  0.88
2011 Pedrelli P, Bitran S, Shyu I, Baer L, Guidi J, Tucker DD, Vitali M, Fava M, Zisook S, Farabaugh AH. Compulsive alcohol use and other high-risk behaviors among college students. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 20: 14-20. PMID 21175916 DOI: 10.1111/J.1521-0391.2010.00090.X  0.88
2011 Perlis RH, Uher R, Ostacher M, Goldberg JF, Trivedi MH, Rush AJ, Fava M. Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. Archives of General Psychiatry. 68: 351-60. PMID 21135313 DOI: 10.1001/Archgenpsychiatry.2010.179  0.44
2011 Pedrelli P, Farabaugh AH, Zisook S, Tucker D, Rooney K, Katz J, Clain AJ, Petersen TJ, Fava M. Gender, depressive symptoms and patterns of alcohol use among college students. Psychopathology. 44: 27-33. PMID 20980785 DOI: 10.1159/000315358  0.88
2011 Yeung AS, Ameral VE, Chuzi SE, Fava M, Mischoulon D. A pilot study of acupuncture augmentation therapy in antidepressant partial and non-responders with major depressive disorder. Journal of Affective Disorders. 130: 285-9. PMID 20692042 DOI: 10.1016/j.jad.2010.07.025  0.68
2011 DeBattista C, Kinrys G, Hoffman D, Goldstein C, Zajecka J, Kocsis J, Teicher M, Potkin S, Preda A, Multani G, Brandt L, Schiller M, Iosifescu D, Fava M. The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression. Journal of Psychiatric Research. 45: 64-75. PMID 20598710 DOI: 10.1016/J.Jpsychires.2010.05.009  0.88
2011 Iovieno N, Dalton ED, Fava M, Mischoulon D. Second-tier natural antidepressants: review and critique. Journal of Affective Disorders. 130: 343-57. PMID 20579741 DOI: 10.1016/j.jad.2010.06.010  0.68
2011 Guidi J, Fava GA, Fava M, Papakostas GI. Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis. Psychological Medicine. 41: 321-31. PMID 20444307 DOI: 10.1017/S0033291710000826  0.64
2011 Merlo-Pich E, Alexander RC, Fava M, Gomeni R. Response to clinical trials of antidepressants: Enrichment strategies' and the placebo response is part of good medicine Clinical Pharmacology and Therapeutics. 89: 486-487. DOI: 10.1038/clpt.2010.339  0.88
2010 Murphy JM, Gilman SE, Lesage A, Horton NJ, Rasic D, Trinh NH, Alamiri B, Sobol AM, Fava M, Smoller JW. Time trends in mortality associated with depression: findings from the Stirling County study. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 55: 776-83. PMID 21172098 DOI: 10.1177/070674371005501205  0.88
2010 Blood AJ, Iosifescu DV, Makris N, Perlis RH, Kennedy DN, Dougherty DD, Kim BW, Lee MJ, Wu S, Lee S, Calhoun J, Hodge SM, Fava M, Rosen BR, Smoller JW, et al. Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorder. Plos One. 5: e13945. PMID 21124764 DOI: 10.1371/Journal.Pone.0013945  0.88
2010 Fava M, Mischoulon D. Evidence for folate in combination with antidepressants at initiation of therapy. The Journal of Clinical Psychiatry. 71: e31. PMID 21114944 DOI: 10.4088/JCP.8157tx4c  0.68
2010 Perlis RH, Huang J, Purcell S, Fava M, Rush AJ, Sullivan PF, Hamilton SP, McMahon FJ, Schulze TG, Schulze T, Potash JB, Zandi PP, Willour VL, Penninx BW, Boomsma DI, et al. Genome-wide association study of suicide attempts in mood disorder patients. The American Journal of Psychiatry. 167: 1499-507. PMID 21041247 DOI: 10.1176/Appi.Ajp.2010.10040541  0.88
2010 Yeung A, Shyu I, Fisher L, Wu S, Yang H, Fava M. Culturally sensitive collaborative treatment for depressed chinese americans in primary care. American Journal of Public Health. 100: 2397-402. PMID 20966373 DOI: 10.2105/AJPH.2009.184911  0.56
2010 Merlo-Pich E, Alexander RC, Fava M, Gomeni R. A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs. Clinical Pharmacology and Therapeutics. 88: 634-42. PMID 20861834 DOI: 10.1038/clpt.2010.159  0.88
2010 Huang J, Perlis RH, Lee PH, Rush AJ, Fava M, Sachs GS, Lieberman J, Hamilton SP, Sullivan P, Sklar P, Purcell S, Smoller JW. Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. The American Journal of Psychiatry. 167: 1254-63. PMID 20713499 DOI: 10.1176/Appi.Ajp.2010.09091335  0.88
2010 Janes AC, Pizzagalli DA, Richardt S, Frederick Bde B, Holmes AJ, Sousa J, Fava M, Evins AE, Kaufman MJ. Neural substrates of attentional bias for smoking-related cues: an FMRI study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2339-45. PMID 20703221 DOI: 10.1038/Npp.2010.103  0.88
2010 Dording CM, Mischoulon D, Goodness TM, Baer L, Clain A, Stewart JW, Matthews JD, McGrath PJ, Nierenberg AA, Fava M, Papakostas GI. Psychoticism and paranoid ideation in patients with nonpsychotic major depressive disorder: prevalence, response to treatment, and impact on short- and long-term treatment outcome. Cns Spectrums. 15: 515-21. PMID 20703198 DOI: 10.1017/S1092852900000468  0.88
2010 Farabaugh A, Sonawalla S, Johnson DP, Witte J, Papakostas GI, Goodness T, Clain A, Baer L, Mischoulon D, Fava M, Harley R. Early improvements in anxiety, depression, and anger/hostility symptoms and response to antidepressant treatment. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 22: 166-71. PMID 20680189  0.68
2010 Sunderajan P, Gaynes BN, Wisniewski SR, Miyahara S, Fava M, Akingbala F, DeVeaugh-Geiss J, Rush AJ, Trivedi MH. Insomnia in patients with depression: a STAR*D report. Cns Spectrums. 15: 394-404. PMID 20625372 DOI: 10.1017/S1092852900029266  0.88
2010 Papakostas GI, Mischoulon D, Shyu I, Alpert JE, Fava M. S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. The American Journal of Psychiatry. 167: 942-8. PMID 20595412 DOI: 10.1176/Appi.Ajp.2009.09081198  0.88
2010 Freeman MP, Mischoulon D, Tedeschini E, Goodness T, Cohen LS, Fava M, Papakostas GI. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants. The Journal of Clinical Psychiatry. 71: 682-8. PMID 20573327 DOI: 10.4088/JCP.10r05976blu  0.88
2010 Freeman MP, Fava M, Lake J, Trivedi MH, Wisner KL, Mischoulon D. Complementary and alternative medicine in major depressive disorder: the American Psychiatric Association Task Force report. The Journal of Clinical Psychiatry. 71: 669-81. PMID 20573326 DOI: 10.4088/JCP.10cs05959blu  0.88
2010 Fornaro M, Iovieno N, Clementi N, Boscaro M, Paggi F, Balercia G, Fava M, Papakostas GI. Diagnosis of co-morbid axis-I psychiatric disorders among women with newly diagnosed, untreated endocrine disorders. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 991-6. PMID 20569197 DOI: 10.3109/15622975.2010.491126  0.64
2010 Kim BW, Kennedy DN, Lehár J, Lee MJ, Blood AJ, Lee S, Perlis RH, Smoller JW, Morris R, Fava M, Breiter HC. Recurrent, robust and scalable patterns underlie human approach and avoidance. Plos One. 5: e10613. PMID 20532247 DOI: 10.1371/Journal.Pone.0010613  0.88
2010 Warden D, Trivedi MH, Wisniewski SR, Kurian B, Zisook S, Kornstein SG, Friedman ES, Miyahara S, Leuchter AF, Fava M, Rush AJ. Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report. Journal of Clinical Psychopharmacology. 30: 259-66. PMID 20473060 DOI: 10.1097/Jcp.0B013E3181Dbfd04  0.88
2010 Farabaugh AH, Bitran S, Witte J, Alpert J, Chuzi S, Clain AJ, Baer L, Fava M, McGrath PJ, Dording C, Mischoulon D, Papakostas GI. Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome. International Clinical Psychopharmacology. 25: 214-7. PMID 20400905 DOI: 10.1097/Yic.0B013E328339Fbbd  0.88
2010 Pedrelli P, Baer L, Losifescu DV, Fava M. Relationship between residual symptoms of depression and self-reported cognitive impairment. Cns Spectrums. 15: 46-51. PMID 20394184 DOI: 10.1017/S1092852900000298  0.88
2010 Binder EB, Owens MJ, Liu W, Deveau TC, Rush AJ, Trivedi MH, Fava M, Bradley B, Ressler KJ, Nemeroff CB. Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response. Archives of General Psychiatry. 67: 369-79. PMID 20368512 DOI: 10.1001/Archgenpsychiatry.2010.18  0.88
2010 Perlis RH, Smoller JW, Mysore J, Sun M, Gillis T, Purcell S, Rietschel M, Nöthen MM, Witt S, Maier W, Iosifescu DV, Sullivan P, Rush AJ, Fava M, Breiter H, et al. Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder. The American Journal of Psychiatry. 167: 574-9. PMID 20360314 DOI: 10.1176/Appi.Ajp.2009.09070973  0.88
2010 Farabaugh A, Locascio JJ, Yap L, Growdon J, Fava M, Crawford C, Matthews J, McCutchen J, Buchin J, Pava J, Alpert JE. Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder. Psychosomatics. 51: 124-9. PMID 20332287 DOI: 10.1176/appi.psy.51.2.124  0.88
2010 Tedeschini E, Fava M, Goodness TM, Papakostas GI. Relationship between probability of receiving placebo and probability of prematurely discontinuing treatment in double-blind, randomized clinical trials for MDD: a meta-analysis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 562-7. PMID 20219330 DOI: 10.1016/j.euroneuro.2010.02.004  0.64
2010 Papakostas GI, Charles D, Fava M. Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 300-7. PMID 20218793 DOI: 10.3109/15622970701432528  0.64
2010 Perlis RH, Ostacher M, Fava M, Nierenberg AA, Sachs GS, Rosenbaum JF. Assuring that double-blind is blind. The American Journal of Psychiatry. 167: 250-2. PMID 20194487 DOI: 10.1176/appi.ajp.2009.09060820  0.88
2010 Yang H, Sinicropi-Yao L, Chuzi S, Youn SJ, Clain A, Baer L, Chen Y, McGrath PJ, Fava M, Papakostas GI. Residual sleep disturbance and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine. Annals of General Psychiatry. 9: 10. PMID 20187924 DOI: 10.1186/1744-859X-9-10  0.64
2010 Janes AC, Pizzagalli DA, Richardt S, deB Frederick B, Chuzi S, Pachas G, Culhane MA, Holmes AJ, Fava M, Evins AE, Kaufman MJ. Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biological Psychiatry. 67: 722-9. PMID 20172508 DOI: 10.1016/J.Biopsych.2009.12.034  0.88
2010 Bryan C, Songer T, Brooks MM, Rush AJ, Thase ME, Gaynes B, Balasubramani GK, Trivedi MH, Fava M, Wisniewski SR. The impact of diabetes on depression treatment outcomes. General Hospital Psychiatry. 32: 33-41. PMID 20114126 DOI: 10.1016/J.Genhosppsych.2009.07.009  0.88
2010 Morris DW, Trivedi MH, Husain MM, Fava M, Budhwar N, Wisniewski SR, Miyahara S, Gollan JK, Davis LL, Daly EJ, Rush AJ. Indicators of pretreatment suicidal ideation in adults with major depressive disorder. Acta Psychiatrica Scandinavica. 121: 480-4. PMID 19958307 DOI: 10.1111/J.1600-0447.2009.01516.X  0.88
2010 Davis LL, Wisniewski SR, Howland RH, Trivedi MH, Husain MM, Fava M, McGrath PJ, Balasubramani GK, Warden D, Rush AJ. Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes. Drug and Alcohol Dependence. 107: 161-70. PMID 19945804 DOI: 10.1016/J.Drugalcdep.2009.10.003  0.88
2010 Papakostas GI, Clain A, Ameral VE, Baer L, Brintz C, Smith WT, Londborg PD, Glaudin V, Painter JR, Fava M. Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study. International Clinical Psychopharmacology. 25: 17-21. PMID 19898245 DOI: 10.1097/YIC.0b013e32833205a4  0.64
2010 Chandler GM, Iosifescu DV, Pollack MH, Targum SD, Fava M. RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). Cns Neuroscience & Therapeutics. 16: 322-5. PMID 19769599 DOI: 10.1111/J.1755-5949.2009.00102.X  0.44
2010 Papakostas GI, Chuzi SE, Sousa JL, Fava M. 5HT1A-mediated stimulation of cortisol release in major depression: use of non-invasive cortisol measurements to predict clinical response. European Archives of Psychiatry and Clinical Neuroscience. 260: 175-80. PMID 19641981 DOI: 10.1007/s00406-009-0035-z  0.64
2010 Yang H, Chuzi S, Sinicropi-Yao L, Johnson D, Chen Y, Clain A, Baer L, McGrath PJ, Stewart JW, Fava M, Papakostas GI. Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine. European Archives of Psychiatry and Clinical Neuroscience. 260: 145-50. PMID 19572158 DOI: 10.1007/s00406-009-0031-3  0.64
2010 Leuchter AF, Husain MM, Cook IA, Trivedi MH, Wisniewski SR, Gilmer WS, Luther JF, Fava M, Rush AJ. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report. Psychological Medicine. 40: 239-51. PMID 19493369 DOI: 10.1017/S0033291709006035  0.88
2010 Nierenberg AA, Husain MM, Trivedi MH, Fava M, Warden D, Wisniewski SR, Miyahara S, Rush AJ. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychological Medicine. 40: 41-50. PMID 19460188 DOI: 10.1017/S0033291709006011  0.88
2010 Casamassima F, Huang J, Fava M, Sachs GS, Smoller JW, Cassano GB, Lattanzi L, Fagerness J, Stange JP, Perlis RH. Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 303-9. PMID 19388002 DOI: 10.1002/ajmg.b.30962  0.88
2010 Stewart JW, McGrath PJ, Fava M, Wisniewski SR, Zisook S, Cook I, Nierenberg AA, Trivedi MH, Balasubramani GK, Warden D, Lesser I, John Rush A. Do atypical features affect outcome in depressed outpatients treated with citalopram? The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 15-30. PMID 19341509 DOI: 10.1017/S1461145709000182  0.88
2010 Farabaugh A, Locascio JJ, Yap L, Growdon J, Fava M, Crawford C, Matthews J, McCutchen J, Buchin J, Pava J, Alpert JE. Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder. Psychosomatics. 51: 124-129. DOI: 10.1016/S0033-3182(10)70672-1  0.88
2010 Petersen TJ, Pava JA, Buchin J, Matthews JD, Papakostas GI, Nierenberg AA, Holmes AJ, Bogdan R, Graves LM, Harley RM, Fava M. The role of cognitive-behavioral therapy and fluoxetine in prevention of recurrence of major depressive disorder Cognitive Therapy and Research. 34: 13-23. DOI: 10.1007/s10608-007-9166-6  0.88
2009 Miller KK, Perlis RH, Papakostas GI, Mischoulon D, Losifescu DV, Brick DJ, Fava M. Low-dose transdermal testosterone augmentation therapy improves depression severity in women. Cns Spectrums. 14: 688-94. PMID 20394176 DOI: 10.1017/S1092852900023944  0.88
2009 Nelson JC, Thase ME, Trivedi MH, Fava M, Han J, Van Tran Q, Pikalov A, Qi Y, Carlson BX, Marcus RN, Berman RM. Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and CN138-163). Primary Care Companion to the Journal of Clinical Psychiatry. 11: 344-52. PMID 20098527 DOI: 10.4088/PCC.08m00744gre  0.88
2009 Janes AC, Frederick Bd, Richardt S, Burbridge C, Merlo-Pich E, Renshaw PF, Evins AE, Fava M, Kaufman MJ. Brain fMRI reactivity to smoking-related images before and during extended smoking abstinence. Experimental and Clinical Psychopharmacology. 17: 365-73. PMID 19968401 DOI: 10.1037/A0017797  0.88
2009 Fava M, Mischoulon D. Folate in depression: efficacy, safety, differences in formulations, and clinical issues. The Journal of Clinical Psychiatry. 70: 12-7. PMID 19909688 DOI: 10.4088/JCP.8157su1c.03  0.68
2009 Gaynes BN, Warden D, Trivedi MH, Wisniewski SR, Fava M, Rush AJ. What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatric Services (Washington, D.C.). 60: 1439-45. PMID 19880458 DOI: 10.1176/Ps.2009.60.11.1439  0.88
2009 Farabaugh AH, Locascio JJ, Yap L, Weintraub D, McDonald WM, Agoston M, Alpert JE, Growdon J, Fava M. Pattern of depressive symptoms in Parkinson's disease. Psychosomatics. 50: 448-54. PMID 19855029 DOI: 10.1016/S0033-3182(09)70836-9  0.88
2009 Warden D, Trivedi MH, Wisniewski SR, Lesser IM, Mitchell J, Balasubramani GK, Fava M, Shores-Wilson K, Stegman D, Rush AJ. Identifying risk for attrition during treatment for depression. Psychotherapy and Psychosomatics. 78: 372-9. PMID 19738403 DOI: 10.1159/000235977  0.88
2009 Leuchter AF, Cook IA, Marangell LB, Gilmer WS, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, McCracken JT, Fava M, Iosifescu D, Greenwald S. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Research. 169: 124-31. PMID 19712979 DOI: 10.1016/J.Psychres.2009.06.004  0.88
2009 Kashner TM, Trivedi MH, Wicker A, Fava M, Wisniewski SR, Rush AJ. The impact of nonclinical factors on care use for patients with depression: a STAR*D report. Cns Neuroscience & Therapeutics. 15: 320-32. PMID 19712127 DOI: 10.1111/J.1755-5949.2009.00091.X  0.88
2009 Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Research. 169: 132-8. PMID 19709754 DOI: 10.1016/J.Psychres.2009.04.004  0.88
2009 Mischoulon D, Papakostas GI, Dording CM, Farabaugh AH, Sonawalla SB, Agoston AM, Smith J, Beaumont EC, Dahan LE, Alpert JE, Nierenberg AA, Fava M. A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder. The Journal of Clinical Psychiatry. 70: 1636-44. PMID 19709502 DOI: 10.4088/Jcp.08M04603  0.88
2009 Kashner TM, Trivedi MH, Wicker A, Fava M, Shores-Wilson K, Wisniewski SR, Rush AJ. Release bias in accessing medical records in clinical trials: a STAR*D report. International Journal of Methods in Psychiatric Research. 18: 147-58. PMID 19701922 DOI: 10.1002/Mpr.286  0.88
2009 Rush AJ, Warden D, Wisniewski SR, Fava M, Trivedi MH, Gaynes BN, Nierenberg AA. STAR*D: revising conventional wisdom. Cns Drugs. 23: 627-47. PMID 19594193 DOI: 10.2165/00023210-200923080-00001  0.88
2009 Fava M, Wisniewski SR, Thase ME, Baker RA, Tran QV, Pikalov A, Yang H, Marcus RN, Berman RM. Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: a pooled analysis of 2 studies. Journal of Clinical Psychopharmacology. 29: 362-7. PMID 19593176 DOI: 10.1097/Jcp.0B013E3181Ac9B0B  0.88
2009 Iosifescu DV, Greenwald S, Devlin P, Mischoulon D, Denninger JW, Alpert JE, Fava M. Frontal EEG predictors of treatment outcome in major depressive disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 772-7. PMID 19574030 DOI: 10.1016/J.Euroneuro.2009.06.001  0.88
2009 Kaufman MJ, Prescot AP, Ongur D, Evins AE, Barros TL, Medeiros CL, Covell J, Wang L, Fava M, Renshaw PF. Oral glycine administration increases brain glycine/creatine ratios in men: a proton magnetic resonance spectroscopy study. Psychiatry Research. 173: 143-9. PMID 19556112 DOI: 10.1016/J.Pscychresns.2009.03.004  0.88
2009 Dording CM, Sinicropi-Yao L, Papakostas G, Matthews JD, Nierenberg AA, Fava M, Mischoulon D. The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder. Nordic Journal of Psychiatry. 63: 420-5. PMID 19521922 DOI: 10.1080/08039480903015396  0.88
2009 Yeung A, Johnson DP, Trinh NH, Weng WC, Kvedar J, Fava M. Feasibility and effectiveness of telepsychiatry services for chinese immigrants in a nursing home. Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association. 15: 336-41. PMID 19441951 DOI: 10.1089/tmj.2008.0138  0.88
2009 Pizzagalli DA, Holmes AJ, Dillon DG, Goetz EL, Birk JL, Bogdan R, Dougherty DD, Iosifescu DV, Rauch SL, Fava M. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. The American Journal of Psychiatry. 166: 702-10. PMID 19411368 DOI: 10.1176/appi.ajp.2008.08081201  0.88
2009 Berman RM, Fava M, Thase ME, Trivedi MH, Swanink R, McQuade RD, Carson WH, Adson D, Taylor L, Hazel J, Marcus RN. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants. Cns Spectrums. 14: 197-206. PMID 19407731 DOI: 10.1017/S1092852900020216  0.88
2009 Gasic GP, Smoller JW, Perlis RH, Sun M, Lee S, Kim BW, Lee MJ, Holt DJ, Blood AJ, Makris N, Kennedy DK, Hoge RD, Calhoun J, Fava M, Gusella JF, et al. BDNF, relative preference, and reward circuitry responses to emotional communication. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 150: 762-81. PMID 19388013 DOI: 10.1002/Ajmg.B.30944  0.88
2009 Friedman ES, Wisniewski SR, Gilmer W, Nierenberg AA, Rush AJ, Fava M, Zisook S, Balasubramani GK, Trivedi MH. Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial. Depression and Anxiety. 26: 612-21. PMID 19382183 DOI: 10.1002/Da.20568  0.88
2009 Wisniewski SR, Rush AJ, Nierenberg AA, Gaynes BN, Warden D, Luther JF, McGrath PJ, Lavori PW, Thase ME, Fava M, Trivedi MH. Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. The American Journal of Psychiatry. 166: 599-607. PMID 19339358 DOI: 10.1176/Appi.Ajp.2008.08071027  0.88
2009 Morris DW, Trivedi MH, Fava M, Wisniewski SR, Balasubramani GK, Khan AY, Jain S, Rush AJ. Diurnal mood variation in outpatients with major depressive disorder. Depression and Anxiety. 26: 851-63. PMID 19306304 DOI: 10.1002/Da.20557  0.88
2009 Kashner TM, Trivedi MH, Wicker A, Fava M, Greist JH, Mundt JC, Shores-Wilson K, Rush AJ, Wisniewski SR. Voice response system to measure healthcare costs: a STAR*D report. The American Journal of Managed Care. 15: 153-62. PMID 19298096  0.88
2009 Perlis RH, Laje G, Smoller JW, Fava M, Rush AJ, McMahon FJ. Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1819-28. PMID 19295509 DOI: 10.1038/npp.2009.4  0.44
2009 Feldman G, Harley R, Kerrigan M, Jacobo M, Fava M. Change in emotional processing during a dialectical behavior therapy-based skills group for major depressive disorder. Behaviour Research and Therapy. 47: 316-21. PMID 19232571 DOI: 10.1016/j.brat.2009.01.005  0.88
2009 Fava M, Iosifescu DV, Pedrelli P, Baer L. Reliability and validity of the Massachusetts general hospital cognitive and physical functioning questionnaire. Psychotherapy and Psychosomatics. 78: 91-7. PMID 19218827 DOI: 10.1159/000201934  0.88
2009 Zisook S, Trivedi MH, Warden D, Lebowitz B, Thase ME, Stewart JW, Moutier C, Fava M, Wisniewski SR, Luther J, Rush AJ. Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study. Journal of Affective Disorders. 117: 63-73. PMID 19217668 DOI: 10.1016/J.Jad.2009.01.002  0.88
2009 Perlis RH, Fava M, Trivedi MH, Alpert J, Luther JF, Wisniewski SR, Rush AJ. Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder. Acta Psychiatrica Scandinavica. 119: 282-9. PMID 19207123 DOI: 10.1111/J.1600-0447.2008.01298.X  0.88
2009 Husain MM, Rush AJ, Wisniewski SR, McClintock SM, Fava M, Nierenberg AA, Davis L, Balasubramani GK, Young E, Albala AA, Trivedi MH. Family history of depression and therapeutic outcome: findings from STAR*D. The Journal of Clinical Psychiatry. 70: 185-95. PMID 19192454 DOI: 10.4088/Jcp.07M03571  0.88
2009 Matthews JD, Siefert C, Dording C, Denninger JW, Park L, van Nieuwenhuizen AO, Sklarsky K, Hilliker S, Homberger C, Rooney K, Fava M. An open study of aripiprazole and escitalopram for psychotic major depressive disorder. Journal of Clinical Psychopharmacology. 29: 73-6. PMID 19142112 DOI: 10.1097/Jcp.0B013E318193Dfb4  0.88
2009 Papakostas GI, Cooper-Kazaz R, Appelhof BC, Posternak MA, Johnson DP, Klibanski A, Lerer B, Fava M. Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies. International Clinical Psychopharmacology. 24: 19-25. PMID 19092448 DOI: 10.1097/YIC.0b013e328314dfaf  0.64
2009 Sullivan PF, de Geus EJ, Willemsen G, James MR, Smit JH, Zandbelt T, Arolt V, Baune BT, Blackwood D, Cichon S, Coventry WL, Domschke K, Farmer A, Fava M, Gordon SD, et al. Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Molecular Psychiatry. 14: 359-75. PMID 19065144 DOI: 10.1038/Mp.2008.125  0.88
2009 Guidi J, Pender M, Hollon SD, Zisook S, Schwartz FH, Pedrelli P, Farabaugh A, Fava M, Petersen TJ. The prevalence of compulsive eating and exercise among college students: an exploratory study. Psychiatry Research. 165: 154-62. PMID 19046604 DOI: 10.1016/J.Psychres.2007.10.005  0.88
2009 Howland RH, Rush AJ, Wisniewski SR, Trivedi MH, Warden D, Fava M, Davis LL, Balasubramani GK, McGrath PJ, Berman SR. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. Drug and Alcohol Dependence. 99: 248-60. PMID 18986774 DOI: 10.1016/J.Drugalcdep.2008.08.010  0.88
2009 Papakostas GI, Fava M. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 34-40. PMID 18823760 DOI: 10.1016/j.euroneuro.2008.08.009  0.64
2009 Young EA, Kornstein SG, Marcus SM, Harvey AT, Warden D, Wisniewski SR, Balasubramani GK, Fava M, Trivedi MH, John Rush A. Sex differences in response to citalopram: a STAR*D report. Journal of Psychiatric Research. 43: 503-11. PMID 18752809 DOI: 10.1016/J.Jpsychires.2008.07.002  0.88
2009 Mischoulon D, Fava M, Stahl SM. Reply to Folate Supplementation: Is It Safe and Effective? The Journal of Clinical Psychiatry. 70: 767-769. DOI: 10.4088/Jcp.081R04824A  0.68
2009 Cockram CA, Doros G, Figueiredo JMd, Karger T, Sonino N, Peruzzi P, Porcelli P, Bellomo A, Quartesan R, Altamura M, Iuso S, Ciannameo I, Piselli M, Elisei S, Fava GA, ... ... Fava M, et al. Contents Vol. 78, 2009 Psychotherapy and Psychosomatics. 78. DOI: 10.1159/000242423  0.64
2009 Cockram CA, Doros G, Figueiredo JMd, Karger T, Sonino N, Peruzzi P, Porcelli P, Bellomo A, Quartesan R, Altamura M, Iuso S, Ciannameo I, Piselli M, Elisei S, Fava GA, ... ... Fava M, et al. Subject Index Vol. 78, 2009 Psychotherapy and Psychosomatics. 78: 397-398. DOI: 10.1159/000242422  0.64
2009 Nierenberg AA, Trivedi MH, Gaynes BN, Mitchell J, Davis LL, Husain MM, Wisniewski SR, Fava M, Warden D, Luther JF, Van Nieuwenhuizen AO, Morris DW, Shelton RC, John Rush A. Effectiveness study of venlafaxine-XR combined with aripiprazole for chronic or recurrent major depressive disorder Australian and New Zealand Journal of Psychiatry. 43: 956-967. DOI: 10.1080/00048670903001885  0.88
2009 Yeung A, Feldman G, Fava M. Self-management of depression: A manual for mental health and primary care professionals Self-Management of Depression: a Manual For Mental Health and Primary Care Professionals. 1-206. DOI: 10.1017/CBO9780511642128  0.88
2009 Parikh R, Sonawalla S, Sharma-Pandey S, Farabaugh A, Yeung A, Safren S, Fava M. P.2.a.03l A cross-cultural, comparative study of the prevalence and symptom patterns of depression among college students European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70580-2  0.56
2008 Foster CE, Webster MC, Weissman MM, Pilowsky DJ, Wickramaratne PJ, Rush AJ, Hughes CW, Garber J, Malloy E, Cerda G, Kornstein SG, Alpert JE, Wisniewski SR, Trivedi MH, Fava M, et al. Course and Severity of Maternal Depression: Associations with Family Functioning and Child Adjustment. Journal of Youth and Adolescence. 37: 906-916. PMID 25013241 DOI: 10.1007/S10964-007-9216-0  0.88
2008 Mischoulon D, Fava M. Are nutritional supplements ready for prime time? The Journal of Clinical Psychiatry. 69: 1497-8. PMID 19193349 DOI: 10.4088/Jcp.V69N0918  0.68
2008 Gelenberg AJ, Thase ME, Meyer RE, Goodwin FK, Katz MM, Kraemer HC, Potter WZ, Shelton RC, Fava M, Khan A, Trivedi MH, Ninan PT, Mann JJ, Bergeson S, Endicott J, et al. The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies. The Journal of Clinical Psychiatry. 69: 1513-28. PMID 19192434 DOI: 10.4088/Jcp.V69N1001  0.88
2008 Papakostas GI, Fava M. Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder. Dialogues in Clinical Neuroscience. 10: 439-51. PMID 19170401  0.64
2008 McGrath PJ, Khan AY, Trivedi MH, Stewart JW, Morris DW, Wisniewski SR, Miyahara S, Nierenberg AA, Fava M, Rush AJ. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. The Journal of Clinical Psychiatry. 69: 1847-55. PMID 19026268 DOI: 10.4088/Jcp.V69N1201  0.88
2008 Evins AE, Culhane MA, Alpert JE, Pava J, Liese BS, Farabaugh A, Fava M. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. Journal of Clinical Psychopharmacology. 28: 660-6. PMID 19011435 DOI: 10.1097/Jcp.0B013E31818Ad7D6  0.88
2008 Foster CE, Webster MC, Weissman MM, Pilowsky DJ, Wickramaratne PJ, Talati A, Rush AJ, Hughes CW, Garber J, Malloy E, Cerda G, Kornstein SG, Alpert JE, Wisniewski SR, Trivedi MH, ... Fava M, et al. Remission of maternal depression: relations to family functioning and youth internalizing and externalizing symptoms. Journal of Clinical Child and Adolescent Psychology : the Official Journal For the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53. 37: 714-24. PMID 18991123 DOI: 10.1080/15374410802359726  0.88
2008 Pedrelli P, Feldman GC, Vorono S, Fava M, Petersen T. Dysfunctional attitudes and perceived stress predict depressive symptoms severity following antidepressant treatment in patients with chronic depression. Psychiatry Research. 161: 302-8. PMID 18976817 DOI: 10.1016/J.Psychres.2007.08.004  0.88
2008 Makris N, Gasic GP, Kennedy DN, Hodge SM, Kaiser JR, Lee MJ, Kim BW, Blood AJ, Evins AE, Seidman LJ, Iosifescu DV, Lee S, Baxter C, Perlis RH, Smoller JW, ... Fava M, et al. Cortical thickness abnormalities in cocaine addiction--a reflection of both drug use and a pre-existing disposition to drug abuse? Neuron. 60: 174-88. PMID 18940597 DOI: 10.1016/J.Neuron.2008.08.011  0.88
2008 Leuchter AF, Lesser IM, Trivedi MH, Rush AJ, Morris DW, Warden D, Fava M, Wisniewski SR, Luther JF, Perales M, Gaynes BN, Stewart JW. An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder. Journal of Psychiatric Practice. 14: 271-80. PMID 18832958 DOI: 10.1097/01.Pra.0000336754.19566.65  0.88
2008 Dording CM, Fisher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. Cns Neuroscience & Therapeutics. 14: 182-91. PMID 18801111 DOI: 10.1111/j.1755-5949.2008.00052.x  0.68
2008 Papakostas GI, McGrath P, Stewart J, Charles D, Chen Y, Mischoulon D, Dording C, Fava M. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder. Psychiatry Research. 161: 116-20. PMID 18755514 DOI: 10.1016/j.psychres.2008.02.011  0.68
2008 Gilmer WS, Gollan JK, Wisniewski SR, Howland RH, Trivedi MH, Miyahara S, Fleck J, Thase ME, Alpert JE, Nierenberg AA, Warden D, Fava M, Rush AJ. Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report. The Journal of Clinical Psychiatry. 69: 1246-56. PMID 18681756 DOI: 10.4088/Jcp.V69N0807  0.88
2008 Perlis RH, Holt DJ, Smoller JW, Blood AJ, Lee S, Kim BW, Lee MJ, Sun M, Makris N, Kennedy DK, Rooney K, Dougherty DD, Hoge R, Rosenbaum JF, Fava M, et al. Association of a polymorphism near CREB1 with differential aversion processing in the insula of healthy participants. Archives of General Psychiatry. 65: 882-92. PMID 18678793 DOI: 10.1001/Archgenpsychiatry.2008.3  0.88
2008 Rush AJ, Wisniewski SR, Warden D, Luther JF, Davis LL, Fava M, Nierenberg AA, Trivedi MH. Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Archives of General Psychiatry. 65: 870-80. PMID 18678792 DOI: 10.1001/Archpsyc.65.8.870  0.88
2008 Papakostas GI, Stahl SM, Krishen A, Seifert CA, Tucker VL, Goodale EP, Fava M. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies. The Journal of Clinical Psychiatry. 69: 1287-92. PMID 18605812 DOI: 10.4088/Jcp.V69N0812  0.88
2008 Candrian M, Schwartz F, Farabaugh A, Perlis RH, Ehlert U, Fava M. Personality disorders and perceived stress in major depressive disorder. Psychiatry Research. 160: 184-91. PMID 18573540 DOI: 10.1016/J.Psychres.2007.06.014  0.44
2008 Pilowsky DJ, Wickramaratne P, Talati A, Tang M, Hughes CW, Garber J, Malloy E, King C, Cerda G, Sood AB, Alpert JE, Trivedi MH, Fava M, Rush AJ, Wisniewski S, et al. Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study. The American Journal of Psychiatry. 165: 1136-47. PMID 18558646 DOI: 10.1176/Appi.Ajp.2008.07081286  0.88
2008 Mischoulon D, Best-Popescu C, Laposata M, Merens W, Murakami JL, Wu SL, Papakostas GI, Dording CM, Sonawalla SB, Nierenberg AA, Alpert JE, Fava M. A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 639-45. PMID 18539007 DOI: 10.1016/J.Euroneuro.2008.04.011  0.88
2008 Pizzagalli DA, Iosifescu D, Hallett LA, Ratner KG, Fava M. Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task. Journal of Psychiatric Research. 43: 76-87. PMID 18433774 DOI: 10.1016/J.Jpsychires.2008.03.001  0.88
2008 Papakostas GI, Homberger CH, Fava M. A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. Journal of Psychopharmacology (Oxford, England). 22: 843-8. PMID 18308801 DOI: 10.1177/0269881107083808  0.64
2008 Iosifescu DV, Greenwald S, Devlin P, Perlis RH, Denninger JW, Alpert JE, Fava M. Pretreatment frontal EEG and changes in suicidal ideation during SSRI treatment in major depressive disorder. Acta Psychiatrica Scandinavica. 117: 271-6. PMID 18307587 DOI: 10.1111/J.1600-0447.2008.01156.X  0.88
2008 Perlis RH, Moorjani P, Fagerness J, Purcell S, Trivedi MH, Fava M, Rush AJ, Smoller JW. Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2810-9. PMID 18288090 DOI: 10.1038/Npp.2008.6  0.44
2008 Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Balasubramani GK, McGrath PJ, Thase ME, Klinkman M, Nierenberg AA, Yates WR, Fava M. Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: Results from STAR*D Journal of General Internal Medicine. 23: 551-560. PMID 18247097 DOI: 10.1007/S11606-008-0522-3  0.88
2008 Yeung A, Fung F, Yu SC, Vorono S, Ly M, Wu S, Fava M. Validation of the Patient Health Questionnaire-9 for depression screening among Chinese Americans. Comprehensive Psychiatry. 49: 211-7. PMID 18243896 DOI: 10.1016/j.comppsych.2006.06.002  0.88
2008 Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Spencer D, Fava M. The STAR*D study: Treating depression in the real world Cleveland Clinic Journal of Medicine. 75: 57-66. PMID 18236731 DOI: 10.3949/Ccjm.75.1.57  0.88
2008 Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Biggs MM, Zisook S, Leuchter A, Howland R, Warden D, Trivedi MH. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. The American Journal of Psychiatry. 165: 342-51. PMID 18172020 DOI: 10.1176/Appi.Ajp.2007.06111868  0.88
2008 Kozel FA, Trivedi MH, Wisniewski SR, Miyahara S, Husain MM, Fava M, Lebowitz B, Zisook S, Rush AJ. Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 16: 58-64. PMID 18165462 DOI: 10.1097/Jgp.0B013E31815A43D7  0.88
2008 Bryan CJ, Songer TJ, Brooks MM, Thase ME, Gaynes BN, Klinkman M, Rush AJ, Trivedi MH, Fava M, Wisniewski SR. A comparison of baseline sociodemographic and clinical characteristics between major depressive disorder patients with and without diabetes: a STAR*D report. Journal of Affective Disorders. 108: 113-20. PMID 18037497 DOI: 10.1016/J.Jad.2007.10.003  0.88
2008 Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH, Nierenberg AA, Fava M, Wong KK. A detailed examination of cytokine abnormalities in Major Depressive Disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 230-3. PMID 17681762 DOI: 10.1016/J.Euroneuro.2007.06.004  0.64
2008 Matthews JD, Blais M, Park L, Welch C, Baity M, Murakami J, Sklarsky K, Homberger C, Fava M. The impact of galantamine on cognition and mood during electroconvulsive therapy: a pilot study. Journal of Psychiatric Research. 42: 526-31. PMID 17681545 DOI: 10.1016/J.Jpsychires.2007.06.002  0.88
2008 Rush AJ, Kilner J, Fava M, Wisniewski SR, Warden D, Nierenberg AA, Trivedi MH. Clinically relevant findings from STAR*D Psychiatric Annals. 38: 188-193. DOI: 10.3928/00485713-20080301-08  0.88
2007 Papakostas GI, Hallett LA, Smith J, Tossani E, Mascarini A, Burns AM, Birnbaum RJ, Fava M, Alpert JE. A survey of five antidepressant properties influencing clinician's treatment choices in MDD. Neuropsychiatric Disease and Treatment. 3: 169-72. PMID 19300547 DOI: 10.2147/Nedt.2007.3.1.169  0.88
2007 Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR. The STAR*D project results: A comprehensive review of findings Current Psychiatry Reports. 9: 449-459. PMID 18221624 DOI: 10.1007/S11920-007-0061-3  0.88
2007 Davis LL, Frazier EC, Gaynes BN, Trivedi MH, Wisniewski SR, Fava M, Barkin J, Kashner TM, Shelton RC, Alpert JE, Rush AJ. Are depressed outpatients with and without a family history of substance use disorder different? A baseline analysis of the STAR*D cohort. The Journal of Clinical Psychiatry. 68: 1931-8. PMID 18162025 DOI: 10.4088/Jcp.V68N1214  0.88
2007 Mallinckrodt CH, Prakash A, Houston JP, Swindle R, Detke MJ, Fava M. Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram). Neuropsychobiology. 56: 73-85. PMID 18037817 DOI: 10.1159/000111537  0.88
2007 Candrian M, Farabaugh A, Pizzagalli DA, Baer L, Fava M. Perceived stress and cognitive vulnerability mediate the effects of personality disorder comorbidity on treatment outcome in major depressive disorder: a path analysis study. The Journal of Nervous and Mental Disease. 195: 729-37. PMID 17984772 DOI: 10.1097/NMD.0b013e318142cbd5  0.88
2007 Morris DW, Rush AJ, Jain S, Fava M, Wisniewski SR, Balasubramani GK, Khan AY, Trivedi MH. Diurnal mood variation in outpatients with major depressive disorder: Implications for DSM-V from an analysis of the sequenced treatment alternatives to relieve depression study data Journal of Clinical Psychiatry. 68: 1339-1347. PMID 17915971 DOI: 10.4088/Jcp.V68N0903  0.88
2007 Zisook S, Lesser I, Stewart JW, Wisniewski SR, Balasubramani GK, Fava M, Gilmer WS, Dresselhaus TR, Thase ME, Nierenberg AA, Trivedi MH, Rush AJ. Effect of age at onset on the course of major depressive disorder. The American Journal of Psychiatry. 164: 1539-46. PMID 17898345 DOI: 10.1176/Appi.Ajp.2007.06101757  0.88
2007 Fraguas R, Iosifescu DV, Alpert J, Wisniewski SR, Barkin JL, Trivedi MH, Rush AJ, Fava M. Major depressive disorder and comorbid cardiac disease: is there a depressive subtype with greater cardiovascular morbidity? Results from the STAR*D study. Psychosomatics. 48: 418-25. PMID 17878501 DOI: 10.1176/Appi.Psy.48.5.418  0.88
2007 Papakostas GI, Perlis RH, Seifert C, Fava M. Antidepressant dose reduction and the risk of relapse in major depressive disorder. Psychotherapy and Psychosomatics. 76: 266-70. PMID 17700046 DOI: 10.1159/000104702  0.64
2007 Warden D, Trivedi MH, Wisniewski SR, Davis L, Nierenberg AA, Gaynes BN, Zisook S, Hollon SD, Balasubramani GK, Howland R, Fava M, Stewart JW, Rush AJ. Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. The American Journal of Psychiatry. 164: 1189-97. PMID 17671281 DOI: 10.1176/Appi.Ajp.2007.06071225  0.88
2007 Husain MM, Rush AJ, Trivedi MH, McClintock SM, Wisniewski SR, Davis L, Luther JF, Zisook S, Fava M. Pain in depression: STAR*D study findings. Journal of Psychosomatic Research. 63: 113-22. PMID 17662746 DOI: 10.1016/J.Jpsychores.2007.02.009  0.88
2007 Young EA, Kornstein SG, Harvey AT, Wisniewski SR, Barkin J, Fava M, Trivedi MH, Rush AJ. Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression. Psychoneuroendocrinology. 32: 843-53. PMID 17629629 DOI: 10.1016/J.Psyneuen.2007.05.013  0.88
2007 Petersen T, Fava M, Alpert JE, Vorono S, Sanders KM, Mischoulon D. Does psychiatry residency training reflect the "real world" of psychiatry practice? A survey of residency graduates. Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association For Academic Psychiatry. 31: 281-9. PMID 17626190 DOI: 10.1176/Appi.Ap.31.4.281  0.88
2007 Lesser IM, Leuchter AF, Trivedi MH, Davis LL, Wisniewski SR, Balasubramani GK, Fava M, Rush AJ. Insured and non-insured depressed outpatients: how do they compare? Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 19: 73-82. PMID 17612846 DOI: 10.1080/10401230701334671  0.88
2007 Hu XZ, Rush AJ, Charney D, Wilson AF, Sorant AJ, Papanicolaou GJ, Fava M, Trivedi MH, Wisniewski SR, Laje G, Paddock S, McMahon FJ, Manji H, Lipsky RH. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. Archives of General Psychiatry. 64: 783-92. PMID 17606812 DOI: 10.1001/Archpsyc.64.7.783  0.88
2007 Papakostas GI, Shelton RC, Smith J, Fava M. Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis. The Journal of Clinical Psychiatry. 68: 826-831. PMID 17592905 DOI: 10.4088/Jcp.V68N0602  0.64
2007 Papakostas GI, Thase ME, Fava M, Nelson JC, Shelton RC. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents. Biological Psychiatry. 62: 1217-27. PMID 17588546 DOI: 10.1016/j.biopsych.2007.03.027  0.64
2007 Wisniewski SR, Fava M, Trivedi MH, Thase ME, Warden D, Niederehe G, Friedman ES, Biggs MM, Sackeim HA, Shores-Wilson K, McGrath PJ, Lavori PW, Miyahara S, Rush AJ. Acceptability of second-step treatments to depressed outpatients: a STAR*D report. The American Journal of Psychiatry. 164: 753-60. PMID 17475734 DOI: 10.1176/Appi.Ajp.164.5.753  0.88
2007 Thase ME, Friedman ES, Biggs MM, Wisniewski SR, Trivedi MH, Luther JF, Fava M, Nierenberg AA, McGrath PJ, Warden D, Niederehe G, Hollon SD, Rush AJ. Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. The American Journal of Psychiatry. 164: 739-52. PMID 17475733 DOI: 10.1176/Ajp.2007.164.5.739  0.88
2007 Wisniewski SR, Rush AJ, Bryan C, Shelton R, Trivedi MH, Marcus S, Husain MM, Hollon SD, Fava M. Comparison of quality of life measures in a depressed population. The Journal of Nervous and Mental Disease. 195: 219-25. PMID 17468681 DOI: 10.1097/01.Nmd.0000258229.38212.6F  0.88
2007 Papakostas GI, Petersen T, Homberger CH, Green CH, Smith J, Alpert JE, Fava M. Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 19: 5-8. PMID 17453655 DOI: 10.1080/10401230601163451  0.88
2007 Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Balasubramani GK, Spencer DC, Petersen T, Klinkman M, Warden D, Nicholas L, Fava M. Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis. Annals of Family Medicine. 5: 126-34. PMID 17389536 DOI: 10.1370/Afm.641  0.88
2007 Fraguas R, Marci C, Fava M, Iosifescu DV, Bankier B, Loh R, Dougherty DD. Autonomic reactivity to induced emotion as potential predictor of response to antidepressant treatment Psychiatry Research. 151: 169-172. PMID 17360044 DOI: 10.1016/j.psychres.2006.08.008  0.88
2007 Zisook S, Rush AJ, Lesser I, Wisniewski SR, Trivedi M, Husain MM, Balasubramani GK, Alpert JE, Fava M. Preadult onset vs. adult onset of major depressive disorder: a replication study. Acta Psychiatrica Scandinavica. 115: 196-205. PMID 17302619 DOI: 10.1111/J.1600-0447.2006.00868.X  0.88
2007 Perlis RH, Purcell S, Fagerness J, Cusin C, Yamaki L, Fava M, Smoller JW. Clinical and Genetic Dissection of Anger Expression and CREB1 Polymorphisms in Major Depressive Disorder Biological Psychiatry. 62: 536-540. PMID 17300755 DOI: 10.1016/J.Biopsych.2006.10.034  0.44
2007 Iosifescu DV, Renshaw PF, Dougherty DD, Lyoo IK, Lee HK, Fraguas R, Cassano P, Nierenberg AA, Fava M. Major depressive disorder with anger attacks and subcortical MRI white matter hyperintensities. The Journal of Nervous and Mental Disease. 195: 175-8. PMID 17299307 DOI: 10.1097/01.nmd.0000253820.69362.87  0.88
2007 Peterson TJ, Feldman G, Harley R, Fresco DM, Graves L, Holmes A, Bogdan R, Papakostas GI, Bohn L, Lury RA, Fava M, Segal ZV. Extreme response style in recurrent and chronically depressed patients: change with antidepressant administration and stability during continuation treatment. Journal of Consulting and Clinical Psychology. 75: 145-53. PMID 17295573 DOI: 10.1037/0022-006X.75.1.145  0.88
2007 Cusin C, Fava M, Amsterdam JD, Quitkin FM, Reimherr FW, Beasley CM, Rosenbaum JF, Perlis RH. Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications. The Journal of Clinical Psychiatry. 68: 52-57. PMID 17284130 DOI: 10.4088/Jcp.V68N0107  0.64
2007 Perlis RH, Beasley CM, Wines JD, Tamura RN, Cusin C, Shear D, Amsterdam J, Quitkin F, Strong RE, Rosenbaum JF, Fava M. Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes. Psychotherapy and Psychosomatics. 76: 40-6. PMID 17170562 DOI: 10.1159/000096363  0.64
2007 Papakostas GI, Petersen T, Sklarsky KG, Nierenberg AA, Alpert JE, Fava M. Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder. Psychiatry Research. 149: 195-200. PMID 17157390 DOI: 10.1016/J.Psychres.2006.03.014  0.88
2007 Nurnberg HG, Fava M, Gelenberg AJ, Hensley PL, Paine S. Open-label sildenafil treatment of partial and non-responders to double-blind treatment in men with antidepressant-associated sexual dysfunction. International Journal of Impotence Research. 19: 167-75. PMID 16871270 DOI: 10.1038/sj.ijir.3901502  0.88
2007 McGRATH PJ, Stewart JW, Fava M, Trivedi MH, Wisniewski SR, Nierenberg AA, Thase ME, Davis L, Biggs MM, Shores-Wilson K, Luther JF, Warden MBAD, Rush AJ. Dr. McGrath and Colleagues Reply American Journal of Psychiatry. 164: 524-524. DOI: 10.1176/Appi.Ajp.164.3.524-A  0.64
2006 Fava M, Graves LM, Benazzi F, Scalia MJ, Iosifescu DV, Alpert JE, Papakostas GI. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. The Journal of Clinical Psychiatry. 67: 1754-9. PMID 17196056 DOI: 10.4088/Jcp.V67N1113  0.88
2006 Fava M, Rush AJ, Alpert JE, Carmin CN, Balasubramani GK, Wisniewski SR, Trivedi MH, Biggs MM, Shores-Wilson K. What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 51: 823-35. PMID 17195602 DOI: 10.1177/070674370605101304  0.88
2006 Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, ... Fava M, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. The American Journal of Psychiatry. 163: 1905-17. PMID 17074942 DOI: 10.1176/Ajp.2006.163.11.1905  0.88
2006 McGrath PJ, Stewart JW, Quitkin FM, Chen Y, Alpert JE, Nierenberg AA, Fava M, Cheng J, Petkova E. Predictors of relapse in a prospective study of fluoxetine treatment of major depression. The American Journal of Psychiatry. 163: 1542-8. PMID 16946178 DOI: 10.1176/Appi.Ajp.163.9.1542  0.88
2006 McGrath PJ, Stewart JW, Fava M, Trivedi MH, Wisniewski SR, Nierenberg AA, Thase ME, Davis L, Biggs MM, Shores-Wilson K, Luther JF, Niederehe G, Warden D, Rush AJ. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. The American Journal of Psychiatry. 163: 1531-41; quiz 1666. PMID 16946177 DOI: 10.1176/Ajp.2006.163.9.1531  0.64
2006 Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME, McGrath PJ, Alpert JE, Warden D, Luther JF, Niederehe G, Lebowitz B, Shores-Wilson K, Rush AJ. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. The American Journal of Psychiatry. 163: 1519-30; quiz 1665. PMID 16946176 DOI: 10.1176/Ajp.2006.163.9.1519  0.88
2006 Papakostas GI, Nutt DJ, Hallett LA, Tucker VL, Krishen A, Fava M. Resolution of Sleepiness and Fatigue in Major Depressive Disorder: A Comparison of Bupropion and the Selective Serotonin Reuptake Inhibitors Biological Psychiatry. 60: 1350-1355. PMID 16934768 DOI: 10.1016/J.Biopsych.2006.06.015  0.88
2006 Davis LL, Frazier E, Husain MM, Warden D, Trivedi M, Fava M, Cassano P, McGrath PJ, Balasubramani GK, Wisniewski SR, Rush AJ. Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 15: 278-85. PMID 16867922 DOI: 10.1080/10550490600754317  0.88
2006 Papakostas GI, Miller KK, Petersen T, Sklarsky KG, Hilliker SE, Klibanski A, Fava M. Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetine Journal of Clinical Psychiatry. 67: 952-957. PMID 16848655 DOI: 10.4088/Jcp.V67N0612  0.88
2006 Harley R, Petersen T, Scalia M, Papakostas GI, Farabaugh A, Fava M. Problem-solving ability and comorbid personality disorders in depressed outpatients. Depression and Anxiety. 23: 496-501. PMID 16845662 DOI: 10.1002/Da.20194  0.64
2006 Denninger JW, Papakostas GI, Mahal Y, Merens W, Alpert JE, Nierenberg AA, Yeung A, Fava M. Somatic symptoms in outpatients with major depressive disorder treated with fluoxetine. Psychosomatics. 47: 348-52. PMID 16844895 DOI: 10.1176/Appi.Psy.47.4.348  0.88
2006 Fava M, Rush AJ, Wisniewski SR, Nierenberg AA, Alpert JE, McGrath PJ, Thase ME, Warden D, Biggs M, Luther JF, Niederehe G, Ritz L, Trivedi MH. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. The American Journal of Psychiatry. 163: 1161-72. PMID 16816220 DOI: 10.1176/Appi.Ajp.163.7.1161  0.88
2006 Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, Ninan PT, Thase ME, Gelenberg AJ, Kupfer DJ, Regier DA, Rosenbaum JF, Ray O, Schatzberg AF. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1841-53. PMID 16794566 DOI: 10.1038/Sj.Npp.1301131  0.88
2006 Farabaugh AH, Sonawalla SB, Fava M, Pedrelli P, Papakostas GI, Schwartz F, Mischoulon D. Differences in cognitive factors between "true drug" versus "placebo pattern" response to fluoxetine as defined by pattern analysis. Human Psychopharmacology. 21: 221-5. PMID 16783809 DOI: 10.1002/Hup.765  0.88
2006 Khan AY, Carrithers J, Preskorn SH, Lear R, Wisniewski SR, John Rush A, Stegman D, Kelley C, Kreiner K, Nierenberg AA, Fava M. Clinical and demographic factors associated with DSM-IV melancholic depression. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 18: 91-8. PMID 16754414 DOI: 10.1080/10401230600614496  0.64
2006 Fava M, Detke MJ, Balestrieri M, Wang F, Raskin J, Perahia D. Management of depression relapse: re-initiation of duloxetine treatment or dose increase. Journal of Psychiatric Research. 40: 328-36. PMID 16678205 DOI: 10.1016/j.jpsychires.2005.06.005  0.88
2006 McMahon FJ, Buervenich S, Charney D, Lipsky R, Rush AJ, Wilson AF, Sorant AJ, Papanicolaou GJ, Laje G, Fava M, Trivedi MH, Wisniewski SR, Manji H. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. American Journal of Human Genetics. 78: 804-14. PMID 16642436 DOI: 10.1086/503820  0.88
2006 Fava M, Rush AJ. Current status of augmentation and combination treatments for major depressive disorder: A literature review and a proposal for a novel approach to improve practice Psychotherapy and Psychosomatics. 75: 139-153. PMID 16636629 DOI: 10.1159/000091771  0.88
2006 Papakostas GI, Petersen TJ, Perlis RH, Judy AE, Burns AM, Alpert JE, Birnbaum RJ, Fava M. A survey of antidepressant prescribing practices in major depression with comorbid attention-deficit hyperactivity disorder. Journal of Clinical Psychopharmacology. 26: 216-8. PMID 16633159 DOI: 10.1097/01.Jcp.0000203226.79364.5E  0.88
2006 Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biological Psychiatry. 59: 1052-60. PMID 16581036 DOI: 10.1016/j.biopsych.2006.01.016  0.88
2006 Simon NM, Smoller JW, McNamara KL, Maser RS, Zalta AK, Pollack MH, Nierenberg AA, Fava M, Wong KK. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biological Psychiatry. 60: 432-5. PMID 16581033 DOI: 10.1016/J.Biopsych.2006.02.004  0.88
2006 Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ. Medication augmentation after the failure of SSRIs for depression New England Journal of Medicine. 354: 1243-1252. PMID 16554526 DOI: 10.1056/Nejmoa052964  0.88
2006 Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression New England Journal of Medicine. 354: 1231-1242. PMID 16554525 DOI: 10.1056/Nejmoa052963  0.88
2006 Weissman MM, Pilowsky DJ, Wickramaratne PJ, Talati A, Wisniewski SR, Fava M, Hughes CW, Garber J, Malloy E, King CA, Cerda G, Sood AB, Alpert JE, Trivedi MH, Rush AJ, et al. Remissions in maternal depression and child psychopathology: a STAR*D-child report. Jama. 295: 1389-98. PMID 16551710 DOI: 10.1001/Jama.295.12.1389  0.88
2006 Papakostas GI, Worthington JJ, Iosifescu DV, Kinrys G, Burns AM, Fisher LB, Homberger CH, Mischoulon D, Fava M. The combination of duloxetine and bupropion for treatment-resistant major depressive disorder. Depression and Anxiety. 23: 178-81. PMID 16528701 DOI: 10.1002/da.20181  0.68
Show low-probability matches.